Background	Background	NN	0
bacillus	bacillus	NN	B-NP
thuringiensi	thuringiensi	NN	I-NP
(	(	-LRB-	0
Bt	Bt	NNP	B-NP
)	)	-RRB-	0
has	has	VBZ	0
been	been	VBN	0
sold	sold	VBN	0
commericially	commericially	NNS	0
and	and	CC	0
used	used	VBN	0
as	as	IN	0
a	a	DT	0
biopesticide	biopesticide	JJ	B-NP
worldwide	worldwide	NN	I-NP
for	for	IN	0
over	over	IN	0
half	half	PDT	0
a	a	DT	0
century	century	NN	0
.	.	.	0
However	However	RB	0
,	,	,	0
growing	growing	VBG	0
public	public	JJ	B-NP
concern	concern	NN	I-NP
surrounding	surrounding	VBG	0
Bt	Bt	JJ	B-NP
use	use	NN	I-NP
has	has	VBZ	0
sparked	sparked	VBN	0
worldwide	worldwide	JJ	0
debate	debate	NN	0
over	over	IN	0
current	current	JJ	0
policies	policies	NNS	0
[	[	-LRB-	0
1	1	LS	0
]	]	-RRB-	0
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
in	in	IN	0
India	India	NNP	0
,	,	,	0
fear	fear	NN	0
over	over	IN	0
a	a	DT	0
potential	potential	JJ	B-NP
Bombyx	Bombyx	JJ	I-NP
mus	mus	NN	I-NP
(	(	-LRB-	0
silkworm	silkworm	LS	B-NP
)	)	-RRB-	0
epizootic	epizootic	NN	B-NP
,	,	,	0
or	or	CC	0
microbial	microbial	JJ	B-NP
pathogen	pathogen	JJ	I-NP
outbreak	outbreak	NN	I-NP
,	,	,	0
inspired	inspired	VBD	0
a	a	DT	0
governmental	governmental	JJ	B-NP
ban	ban	NN	I-NP
on	on	IN	0
the	the	DT	0
use	use	NN	0
of	of	IN	0
bacillus	bacillus	NN	B-NP
thuringiensi	thuringiensi	NN	I-NP
,	,	,	0
despite	despite	IN	0
the	the	DT	0
nation	nation	NN	0
's	's	POS	0
continuing	continuing	JJ	0
use	use	NN	0
of	of	IN	0
traditional	traditional	JJ	0
chemical	chemical	NN	0
pesticides	pesticides	NNS	0
[	[	-LRB-	0
2	2	LS	0
]	]	-RRB-	0
.	.	.	0
While	While	IN	0
pest	pest	JJ	0
control	control	NN	0
with	with	IN	0
cry	cry	NN	B-NP
toxin	toxin	NN	I-NP
that	that	WDT	0
possess	possess	VBP	0
low	low	JJ	0
B.	B.	NNP	B-NP
mori	mori	JJ	I-NP
activity	activity	NN	I-NP
(	(	-LRB-	0
i.e	i.e	NNP	0
.	.	.	0
Cry1Ac	Cry1Ac	NNP	0
)	)	-RRB-	0
is	is	VBZ	0
a	a	DT	0
viable	viable	JJ	0
solution	solution	NN	B-NP
in	in	IN	0
affected	affected	JJ	0
countries	countries	NNS	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
worthwhile	worthwhile	VBN	0
to	to	TO	0
investigate	investigate	VB	0
the	the	DT	0
specific	specific	JJ	0
molecular	molecular	JJ	B-NP
mechanism	mechanism	NN	I-NP
that	that	WDT	0
make	make	VBP	0
Cry1Aa	Cry1Aa	RB	0
highly	highly	RB	0
active	active	JJ	0
.	.	.	0
Early	Early	JJ	B-NP
work	work	NN	I-NP
took	took	VBD	0
advantage	advantage	NN	0
of	of	IN	0
the	the	DT	0
fact	fact	NN	0
that	that	IN	0
Cry1Aa	Cry1Aa	NNP	0
,	,	,	0
but	but	CC	0
not	not	RB	0
Cry1Ac	Cry1Ac	CD	0
,	,	,	0
is	is	VBZ	0
toxic	toxic	JJ	B-NP
to	to	TO	0
B.	B.	NNP	B-NP
mori	mori	NN	I-NP
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
Ge	Ge	NN	B-NP
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
3	3	LS	0
]	]	-RRB-	0
exchanged	exchanged	VBD	0
hypervariable	hypervariable	JJ	B-NP
region	region	NN	I-NP
between	between	IN	0
genes	genes	NNS	0
encoding	encoding	VBP	0
the	the	DT	0
two	two	CD	0
toxins	toxins	NNS	0
and	and	CC	0
localized	localized	VBN	0
the	the	DT	0
toxicity	toxicity	JJ	0
specifying	specifying	JJ	0
region	region	NN	0
of	of	IN	0
Cry1Aa	Cry1Aa	CD	0
to	to	TO	0
residues	residues	CD	0
332-450	332-450	CD	0
in	in	IN	0
domain	domain	JJ	0
II	II	NNP	0
.	.	.	0
A	A	DT	0
follow-up	follow-up	JJ	B-NP
study	study	NN	I-NP
demonstrated	demonstrated	VBD	0
the	the	DT	0
toxicity	toxicity	JJ	0
specifying	specifying	JJ	0
residues	residues	NNS	0
were	were	VBD	0
involved	involved	VBN	0
in	in	IN	0
binding	binding	JJ	0
b.	b.	NN	B-NP
mori	mori	NNP	I-NP
brush	brush	NN	I-NP
border	border	NN	I-NP
membrane	membrane	NN	I-NP
vesicle	vesicle	NN	I-NP
[	[	-LRB-	0
4	4	LS	0
]	]	-RRB-	0
.	.	.	0
More	More	RBR	0
specifically	specifically	RB	0
,	,	,	0
alanine	alanine	JJ	B-NP
substitution	substitution	NN	I-NP
or	or	CC	0
deletion	deletion	NN	0
of	of	IN	0
residues	residues	CD	0
365	365	CD	0
to	to	TO	0
371	371	CD	0
removed	removed	VBN	0
nearly	nearly	RB	0
all	all	DT	0
toxicity	toxicity	NN	0
and	and	CC	0
binding	binding	VBG	0
to	to	TO	0
B.	B.	NNP	B-NP
mori	mori	NNP	I-NP
BBMV	BBMV	NN	I-NP
[	[	-LRB-	0
5	5	LS	0
]	]	-RRB-	0
.	.	.	0
Recently	Recently	RB	0
,	,	,	0
research	research	NN	0
on	on	IN	0
B.	B.	NNP	B-NP
mori	mori	NN	I-NP
has	has	VBZ	0
focused	focused	VBN	0
on	on	IN	0
purifying	purifying	NN	0
and	and	CC	0
cloning	cloning	VBG	0
the	the	DT	0
midgut	midgut	JJ	B-NP
epithelial	epithelial	NN	I-NP
receptors	receptors	VBP	0
targeted	targeted	VBN	0
by	by	IN	0
Cry1Aa	Cry1Aa	CD	0
toxin	toxin	NN	0
.	.	.	0
The	The	DT	0
first	first	JJ	0
toxin-binding	toxin-binding	JJ	0
receptor	receptor	NN	B-NP
purified	purified	NN	I-NP
from	from	IN	0
B.	B.	NNP	B-NP
mori	mori	NN	I-NP
was	was	VBD	0
a	a	DT	0
120-kDa	120-kDa	FW	0
aminopeptidase	aminopeptidase	NN	B-NP
N	N	NNP	I-NP
(	(	-LRB-	0
aminopeptidase	aminopeptidase	NN	B-NP
n	n	NN	I-NP
)	)	-RRB-	0
,	,	,	0
which	which	WDT	0
appears	appears	VBZ	0
around	around	RB	0
110-kDa	110-kDa	CD	0
on	on	IN	0
sds-page	sds-page	NN	B-NP
gel	gel	NN	I-NP
when	when	WRB	0
preparative	preparative	JJ	B-NP
condition	condition	NN	I-NP
are	are	VBP	0
used	used	VBN	0
that	that	IN	0
cleave	cleave	VBG	0
its	its	PRP$	0
glycosyl-phosphatidylinositol	glycosyl-phosphatidylinositol	JJ	B-NP
(	(	-LRB-	0
GPI	GPI	NNP	0
)	)	-RRB-	0
anchor	anchor	NN	0
.	.	.	0
This	This	DT	0
receptor	receptor	NN	B-NP
was	was	VBD	0
shown	shown	VBN	0
to	to	TO	0
bind	bind	CD	0
Cry1Aa	Cry1Aa	CD	0
with	with	IN	0
a	a	DT	0
7.6	7.6	CD	0
nM	nM	JJ	B-NP
affinity	affinity	NN	I-NP
,	,	,	0
as	as	RB	0
determined	determined	VBN	0
by	by	IN	0
Scatchard	Scatchard	NNP	B-NP
analysis	analysis	NN	I-NP
with	with	IN	0
binding	binding	JJ	B-NP
assay	assay	NN	I-NP
elisa	elisa	NNP	I-NP
[	[	-LRB-	0
6	6	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
was	was	VBD	0
cloned	cloned	VBN	0
and	and	CC	0
expressed	expressed	VBN	0
in	in	IN	0
E.	E.	NNP	B-NP
cus	cus	NN	I-NP
and	and	CC	0
demonstrated	demonstrated	VBN	0
to	to	TO	0
bind	bind	CD	0
Cry1Aa	Cry1Aa	CD	0
toxin	toxin	NN	0
on	on	IN	0
ligand	ligand	JJ	B-NP
blot	blot	NN	I-NP
[	[	-LRB-	0
7	7	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
indicate	indicate	VBP	0
the	the	DT	0
Cry1Aa-APN	Cry1Aa-APN	CD	0
interaction	interaction	NNS	0
was	was	VBD	0
specific	specific	JJ	0
and	and	CC	0
that	that	IN	0
APN	APN	NNP	B-NP
glycosylation	glycosylation	NN	I-NP
was	was	VBD	0
not	not	RB	0
required	required	VBN	0
for	for	IN	0
Cry1Aa	Cry1Aa	CD	0
binding	binding	NNS	0
.	.	.	0
This	This	DT	0
is	is	VBZ	0
not	not	RB	0
altogether	altogether	RB	0
surprising	surprising	JJ	0
because	because	IN	0
Cry1Aa	Cry1Aa	CD	0
binding	binding	NN	0
to	to	TO	0
Manduca	Manduca	NNP	B-NP
sexta	sexta	VBD	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
has	has	VBZ	0
not	not	RB	0
been	been	VBN	0
found	found	VBN	0
to	to	TO	0
be	be	VB	0
modulated	modulated	VBN	0
by	by	IN	0
sugar	sugar	NN	0
binding	binding	NNS	0
[	[	-LRB-	0
8	8	CD	0
]	]	-RRB-	0
and	and	CC	0
the	the	DT	0
B.	B.	NNP	B-NP
mori	mori	NNP	I-NP
APN	APN	NN	I-NP
sequence	sequence	NN	I-NP
is	is	VBZ	0
73.7	73.7	CD	0
%	%	NN	0
identical	identical	NN	0
to	to	TO	0
M.	M.	NNP	0
sexta	sexta	VBD	0
APN-1	APN-1	CD	B-NP
.	.	.	0
sequence	sequence	NN	B-NP
alignment	alignment	NN	I-NP
with	with	IN	0
Plutella	Plutella	NNP	B-NP
xylostella	xylostella	NN	I-NP
APN	APN	NN	I-NP
receptor	receptor	NN	I-NP
indicate	indicate	VBP	0
that	that	IN	0
a	a	DT	0
highly	highly	RB	0
conserved	conserved	JJ	0
region	region	NN	0
of	of	IN	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
likely	likely	JJ	0
functions	functions	NNS	0
as	as	IN	0
the	the	DT	0
toxin	toxin	NN	B-NP
binding	binding	JJ	0
site	site	NN	0
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
By	By	IN	0
testing	testing	NN	0
for	for	IN	0
toxin	toxin	NN	B-NP
binding	binding	VBG	0
to	to	TO	0
lysylendopeptidase-digested	lysylendopeptidase-digested	NNP	B-NP
b.	b.	NN	I-NP
mori	mori	NNP	I-NP
apn	apn	NN	I-NP
fragment	fragment	NN	I-NP
,	,	,	0
the	the	DT	0
toxin	toxin	NN	B-NP
binding	binding	JJ	0
site	site	NN	0
was	was	VBD	0
suggested	suggested	VBN	0
to	to	TO	0
be	be	VB	0
between	between	IN	0
Ile135	Ile135	NNP	B-NP
and	and	CC	0
Pro198	Pro198	NNP	B-NP
.	.	.	0
A	A	DT	0
later	later	JJ	0
study	study	NN	0
by	by	IN	0
these	these	DT	0
authors	authors	NNS	0
identified	identified	VBD	0
120-kDa	120-kDa	CD	0
and	and	CC	0
115-kDa	115-kDa	CD	0
APNs	APNs	JJ	B-NP
coeluting	coeluting	NN	I-NP
from	from	IN	0
an	an	DT	0
anion-exchange	anion-exchange	JJ	B-NP
column	column	NN	I-NP
that	that	WDT	0
together	together	RB	0
yielded	yielded	VBD	0
a	a	DT	0
Cry1Aa	Cry1Aa	JJ	0
affinity	affinity	NN	0
of	of	IN	0
53	53	CD	0
nM	nM	NN	B-NP
[	[	-LRB-	0
10	10	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
APNs	APNs	JJ	0
eluted	eluted	NNS	0
just	just	RB	0
prior	prior	RB	0
to	to	TO	0
a	a	DT	0
120	120	CD	0
kDa	kDa	JJ	B-NP
APN	APN	NN	I-NP
with	with	IN	0
7.6	7.6	CD	0
nM	nM	JJ	B-NP
affinity	affinity	NN	I-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
unclear	unclear	JJ	0
whether	whether	IN	0
the	the	DT	0
120-	120-	NNP	0
and	and	CC	0
115-kDa	115-kDa	CD	0
proteins	proteins	NNS	0
represent	represent	VBP	0
uncleaved	uncleaved	VBN	0
and	and	CC	0
cleaved	cleaved	JJ	0
gpi-anchor	gpi-anchor	NN	B-NP
isozyme	isozyme	NN	I-NP
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
this	this	DT	0
study	study	NN	0
also	also	RB	0
showed	showed	VBD	0
that	that	IN	0
Cry1Ac	Cry1Ac	CD	0
toxin	toxin	NN	0
binds	binds	NN	0
to	to	TO	0
the	the	DT	0
120	120	CD	0
/	/	CD	0
115	115	CD	0
kDa	kDa	JJ	B-NP
APN	APN	NNP	I-NP
fraction	fraction	NN	I-NP
with	with	IN	0
equal	equal	JJ	0
affinity	affinity	NN	B-NP
as	as	IN	0
Cry1Aa	Cry1Aa	NNP	0
,	,	,	0
and	and	CC	0
only	only	RB	0
4-fold	4-fold	RB	0
reduced	reduced	VBN	B-NP
affinity	affinity	VBN	I-NP
to	to	TO	0
the	the	DT	0
isolated	isolated	JJ	0
120-kDa	120-kDa	NNP	0
APN	APN	NNP	0
.	.	.	0
Nonetheless	Nonetheless	RB	0
,	,	,	0
Cry1Aa	Cry1Aa	NNP	0
is	is	VBZ	0
210	210	CD	0
times	times	NNS	0
more	more	RBR	0
toxic	toxic	JJ	B-NP
than	than	IN	0
Cry1Ac	Cry1Ac	CD	0
to	to	TO	0
B.	B.	NNP	B-NP
mus	mus	NN	I-NP
[	[	-LRB-	0
4	4	LS	0
]	]	-RRB-	0
.	.	.	0
As	As	IN	0
a	a	DT	0
whole	whole	NN	0
,	,	,	0
B.	B.	NNP	B-NP
mori	mori	VBD	I-NP
APN	APN	NNP	I-NP
research	research	NN	I-NP
indicates	indicates	VBZ	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
at	at	IN	0
least	least	JJS	0
three	three	CD	0
genetic	genetic	JJ	B-NP
isoform	isoform	NN	I-NP
[	[	-LRB-	0
7	7	CD	0
11	11	CD	0
12	12	CD	0
]	]	-RRB-	0
,	,	,	0
with	with	IN	0
toxin	toxin	NN	B-NP
affinity	affinity	NN	I-NP
ranging	ranging	VBG	0
from	from	IN	0
nanomolar	nanomolar	VBG	0
to	to	TO	0
none	none	NN	0
at	at	IN	0
all	all	DT	0
.	.	.	0
In	In	IN	0
addition	addition	NN	0
to	to	TO	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
,	,	,	0
a	a	DT	0
completely	completely	RB	0
different	different	JJ	0
toxin	toxin	NN	B-NP
receptor	receptor	NN	I-NP
class	class	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
affinity	affinity	JJ	B-NP
precipitated	precipitated	NN	I-NP
by	by	IN	0
toxin	toxin	NN	B-NP
from	from	IN	0
solubilized	solubilized	JJ	B-NP
b.	b.	NN	I-NP
mori	mori	VBD	I-NP
midgut	midgut	JJ	I-NP
protein	protein	NN	I-NP
.	.	.	0
In	In	IN	0
this	this	DT	0
manner	manner	NN	0
,	,	,	0
Nagamatsu	Nagamatsu	NN	B-NP
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
13	13	CD	0
]	]	-RRB-	0
purified	purified	FW	0
a	a	FW	0
175-kDa	175-kDa	FW	0
glycoprotein	glycoprotein	FW	0
(	(	-LRB-	0
BtR175	BtR175	NNP	B-NP
)	)	-RRB-	0
that	that	IN	0
bound	bound	CD	0
Cry1Aa	Cry1Aa	CD	0
toxin	toxin	NN	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
these	these	DT	0
authors	authors	NNS	0
did	did	VBD	0
not	not	RB	0
observe	observe	VBP	0
binding	binding	VBG	0
of	of	IN	0
Cry1Aa	Cry1Aa	CD	0
to	to	TO	0
apn-sized	apn-sized	NN	B-NP
band	band	NN	I-NP
in	in	IN	0
ligand	ligand	JJ	B-NP
blot	blot	JJ	I-NP
study	study	NN	I-NP
with	with	IN	0
BBMV	BBMV	NNP	B-NP
.	.	.	0
antibody	antibody	NN	B-NP
produced	produced	VBN	0
to	to	TO	0
BtR175	BtR175	CD	B-NP
blocked	blocked	JJ	0
toxin	toxin	NN	B-NP
binding	binding	VBG	0
to	to	TO	0
the	the	DT	0
receptor	receptor	NN	B-NP
in	in	IN	0
BBMV	BBMV	NNP	B-NP
.	.	.	0
The	The	DT	0
antibody	antibody	NN	B-NP
serum	serum	VBZ	I-NP
also	also	RB	0
reduced	reduced	VBD	0
Cry1Aa	Cry1Aa	CD	0
activity	activity	NN	0
against	against	IN	0
B.	B.	NNP	B-NP
mori	mori	NN	I-NP
when	when	WRB	0
it	it	PRP	0
was	was	VBD	0
fed	fed	VBN	0
to	to	TO	0
larvae	larvae	VB	0
prior	prior	RB	0
to	to	TO	0
toxin	toxin	NN	B-NP
addition	addition	NN	I-NP
to	to	TO	0
the	the	DT	0
diet	diet	NN	0
[	[	-LRB-	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
same	same	JJ	0
group	group	NN	0
cloned	cloned	NNS	0
and	and	CC	0
introduced	introduced	VBD	0
the	the	DT	0
BtR175	BtR175	JJ	B-NP
gene	gene	NN	I-NP
with	with	IN	0
a	a	DT	0
baculovirus	baculovirus	JJ	B-NP
vector	vector	NN	I-NP
into	into	IN	0
Spodptera	Spodptera	NNP	B-NP
frugiperda	frugiperda	VBD	0
sf9	sf9	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
Addition	Addition	NN	B-NP
of	of	IN	0
Cry1Aa	Cry1Aa	NNP	0
caused	caused	VBD	0
swelling	swelling	VBG	0
and	and	CC	0
lysi	lysi	NN	B-NP
of	of	IN	0
only	only	RB	0
the	the	DT	0
expressing	expressing	VBG	B-NP
btr175	btr175	NN	I-NP
sf9	sf9	NN	I-NP
cell	cell	NN	I-NP
.	.	.	0
Based	Based	VBN	0
on	on	IN	0
sequence	sequence	JJ	B-NP
analysis	analysis	NN	I-NP
,	,	,	0
the	the	DT	0
receptor	receptor	NN	B-NP
was	was	VBD	0
characterized	characterized	VBN	0
as	as	IN	0
a	a	DT	0
cadherin-like	cadherin-like	JJ	B-NP
glycoprotein	glycoprotein	NN	I-NP
containing	containing	VBG	0
nine	nine	CD	0
cadherin	cadherin	CD	B-NP
repeat	repeat	NN	I-NP
,	,	,	0
a	a	DT	0
membrane	membrane	JJ	0
proximal	proximal	JJ	B-NP
region	region	NN	I-NP
,	,	,	0
one	one	CD	0
transmembrane	transmembrane	JJ	B-NP
region	region	NN	I-NP
,	,	,	0
and	and	CC	0
a	a	DT	0
small	small	JJ	0
cytoplasmic	cytoplasmic	JJ	B-NP
domain	domain	NN	I-NP
[	[	-LRB-	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
Ihara	Ihara	NN	B-NP
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
16	16	CD	0
]	]	-RRB-	0
also	also	RB	0
purified	purified	JJ	0
and	and	CC	0
partially	partially	RB	0
sequenced	sequenced	VB	0
what	what	WP	0
was	was	VBD	0
presumed	presumed	VBN	0
to	to	TO	0
be	be	VB	0
the	the	DT	0
same	same	JJ	0
cadherin-like	cadherin-like	JJ	B-NP
receptor	receptor	NN	I-NP
.	.	.	0
binding	binding	JJ	B-NP
study	study	NN	I-NP
indicated	indicated	VBD	0
that	that	IN	0
the	the	DT	0
cadherin	cadherin	NN	B-NP
affinity	affinity	NN	I-NP
for	for	IN	0
Cry1Aa	Cry1Aa	NNP	0
is	is	VBZ	0
equivalent	equivalent	JJ	0
to	to	TO	0
that	that	DT	0
of	of	IN	0
the	the	DT	0
brush	brush	JJ	B-NP
border	border	NN	I-NP
membrane	membrane	NN	I-NP
vesicle	vesicle	NN	I-NP
from	from	IN	0
B.	B.	NNP	B-NP
mus	mus	NN	I-NP
[	[	-LRB-	0
16	16	CD	0
]	]	-RRB-	0
,	,	,	0
an	an	DT	0
affinity	affinity	NN	B-NP
that	that	WDT	0
is	is	VBZ	0
substantially	substantially	RB	0
lower	lower	JJR	0
than	than	IN	0
the	the	DT	0
apn	apn	NN	B-NP
affinity	affinity	NN	I-NP
reported	reported	VBD	0
.	.	.	0
Recently	Recently	RB	0
,	,	,	0
btr175	btr175	NN	B-NP
cdna	cdna	NN	I-NP
variant	variant	JJ	I-NP
have	have	VBP	0
been	been	VBN	0
discovered	discovered	VBN	0
,	,	,	0
showing	showing	VBG	0
at	at	IN	0
least	least	JJS	0
three	three	CD	0
cadherin-like	cadherin-like	JJ	B-NP
receptor	receptor	NNS	I-NP
allele	allele	NN	I-NP
are	are	VBP	0
found	found	VBN	0
in	in	IN	0
B.	B.	NNP	B-NP
mus	mus	NN	I-NP
[	[	-LRB-	0
17	17	CD	0
]	]	-RRB-	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
likely	likely	RB	0
that	that	IN	0
glycosylation	glycosylation	NN	B-NP
plays	plays	VBZ	0
a	a	DT	0
major	major	JJ	0
role	role	NN	0
in	in	IN	0
cadherin-like	cadherin-like	JJ	B-NP
receptor	receptor	NN	I-NP
isoform	isoform	NN	I-NP
as	as	IN	0
well	well	RB	0
,	,	,	0
as	as	IN	0
glycosylation	glycosylation	NN	B-NP
has	has	VBZ	0
been	been	VBN	0
observed	observed	VBN	0
previously	previously	RB	0
for	for	IN	0
the	the	DT	0
M.	M.	NNP	0
sexta	sexta	VBD	0
cadherin-like	cadherin-like	JJ	B-NP
receptor	receptor	NN	I-NP
BT-R	BT-R	JJ	I-NP
1	1	CD	0
[	[	-LRB-	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
Progress	Progress	NN	0
in	in	IN	0
research	research	NN	0
on	on	IN	0
bt	bt	NN	B-NP
toxin	toxin	NN	I-NP
silkworm	silkworm	JJ	I-NP
receptor	receptor	NN	I-NP
has	has	VBZ	0
provided	provided	VBN	0
a	a	DT	0
means	means	NNS	0
for	for	IN	0
assaying	assaying	JJ	0
mutant	mutant	JJ	B-NP
toxin	toxin	NN	I-NP
with	with	IN	0
potentially	potentially	RB	0
altered	altered	VBN	0
binding	binding	JJ	0
and	and	CC	0
activity	activity	NN	0
.	.	.	0
In	In	IN	0
this	this	DT	0
study	study	NN	0
,	,	,	0
we	we	PRP	0
tested	tested	VBD	0
the	the	DT	0
hypothesis	hypothesis	NN	0
that	that	IN	0
Cry1Aa	Cry1Aa	CD	0
binds	binds	NN	0
to	to	TO	0
both	both	PDT	0
the	the	DT	0
120-kDa	120-kDa	NNP	0
B.	B.	NNP	B-NP
mori	mori	VBD	I-NP
APN	APN	NNP	I-NP
and	and	CC	0
the	the	DT	0
175-kDa	175-kDa	NNP	0
B.	B.	NNP	0
mori	mori	VBD	0
cadherin-like	cadherin-like	JJ	0
protein	protein	NN	0
.	.	.	0
Based	Based	VBN	0
on	on	IN	0
the	the	DT	0
previous	previous	JJ	0
work	work	NN	0
of	of	IN	0
Ge	Ge	NNP	B-NP
,	,	,	0
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
3	3	LS	0
]	]	-RRB-	0
and	and	CC	0
Lee	Lee	NNP	0
,	,	,	0
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
4	4	LS	0
]	]	-RRB-	0
,	,	,	0
we	we	PRP	0
also	also	RB	0
postulated	postulated	VBN	0
that	that	IN	0
domain	domain	JJ	0
II	II	NNP	0
of	of	IN	0
Cry1Aa	Cry1Aa	NNP	0
is	is	VBZ	0
the	the	DT	0
significant	significant	JJ	0
binding	binding	JJ	0
domain	domain	NN	0
.	.	.	0
These	These	DT	0
hypotheses	hypotheses	NN	0
were	were	VBD	0
tested	tested	VBN	0
for	for	IN	0
the	the	DT	0
first	first	JJ	0
time	time	NN	0
in	in	IN	0
studies	studies	NNS	0
with	with	IN	0
purified	purified	NN	0
,	,	,	0
native	native	JJ	0
b.	b.	NN	B-NP
mori	mori	NNP	I-NP
receptor	receptor	NN	I-NP
(	(	-LRB-	0
rather	rather	RB	0
than	than	IN	0
BBMV	BBMV	NNP	B-NP
)	)	-RRB-	0
under	under	IN	0
real-time	real-time	JJ	B-NP
,	,	,	0
non-labeled	non-labeled	JJ	B-NP
toxin	toxin	NN	I-NP
binding	binding	JJ	0
conditions	conditions	NNS	0
.	.	.	0
Results	Results	FW	0
Bombyx	Bombyx	NN	B-NP
mori	mori	NNP	I-NP
aminopeptidase	aminopeptidase	NN	I-NP
N	N	NNP	I-NP
and	and	CC	0
cadherin-like	cadherin-like	JJ	B-NP
receptor	receptor	NN	I-NP
purification	purification	NN	I-NP
To	To	TO	0
investigate	investigate	VB	0
the	the	DT	0
specificity	specificity	NN	0
of	of	IN	0
b.	b.	NN	B-NP
mori	mori	NN	I-NP
receptor	receptor	NN	I-NP
cry	cry	NN	I-NP
toxin	toxin	NN	I-NP
,	,	,	0
the	the	DT	0
two	two	CD	0
known	known	VBN	0
b.	b.	NN	B-NP
mori	mori	VBD	I-NP
midgut	midgut	JJ	I-NP
receptor	receptor	NN	I-NP
were	were	VBD	0
purified	purified	VBN	0
from	from	IN	0
B.	B.	NNP	B-NP
mori	mori	VBD	I-NP
BBMV	BBMV	NNP	I-NP
.	.	.	0
Solubilized	Solubilized	NNP	0
b.	b.	NN	B-NP
mori	mori	VBD	I-NP
bbmv	bbmv	NN	I-NP
protein	protein	NN	I-NP
were	were	VBD	0
separated	separated	VBN	0
by	by	IN	0
Q	Q	NNP	B-NP
Sepharose	Sepharose	NNP	I-NP
anion-exchange	anion-exchange	JJ	I-NP
chromatography	chromatography	NN	I-NP
and	and	CC	0
all	all	DT	0
eluted	eluted	JJ	B-NP
fraction	fraction	NN	I-NP
were	were	VBD	0
tested	tested	VBN	0
for	for	IN	0
APN	APN	NNP	B-NP
enzymatic	enzymatic	JJ	I-NP
activity	activity	NN	I-NP
.	.	.	0
Additionally	Additionally	RB	0
,	,	,	0
Cry1Aa	Cry1Aa	CD	0
toxin	toxin	NN	0
binding	binding	JJ	0
capability	capability	NN	0
was	was	VBD	0
assayed	assayed	VBN	0
by	by	IN	0
"slot	"slot	CD	0
blotting	blotting	NN	0
"	"	''	0
all	all	DT	0
fractions	fractions	NN	0
and	and	CC	0
probing	probing	VBG	0
with	with	IN	0
biotin-Cry1Aa	biotin-Cry1Aa	CD	0
.	.	.	0
The	The	DT	0
chromatogram	chromatogram	NN	B-NP
in	in	IN	0
Fig.	Fig.	CD	0
1displays	1displays	CD	0
the	the	DT	0
separation	separation	NN	0
of	of	IN	0
cadherin	cadherin	NN	B-NP
and	and	CC	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
from	from	IN	0
bbmv	bbmv	NN	B-NP
protein	protein	NN	I-NP
.	.	.	0
apn	apn	NN	B-NP
isozyme	isozyme	NN	I-NP
of	of	IN	0
100-	100-	NNP	0
and	and	CC	0
110-kDa	110-kDa	NNP	0
were	were	VBD	0
detected	detected	VBN	0
that	that	WDT	0
did	did	VBD	0
not	not	RB	0
show	show	VB	0
Cry1Aa-binding	Cry1Aa-binding	CD	0
in	in	IN	0
slot	slot	NN	B-NP
blot	blot	NN	I-NP
assay	assay	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
;	;	:	0
fractions	fractions	CD	0
24-25	24-25	CD	0
and	and	CC	0
30-31	30-31	CD	0
)	)	-RRB-	0
.	.	.	0
Such	Such	JJ	0
isozyme	isozyme	NN	B-NP
have	have	VBP	0
been	been	VBN	0
reported	reported	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
11	11	CD	0
12	12	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
a	a	DT	0
115-kDa	115-kDa	NNP	0
APN	APN	NNP	0
was	was	VBD	0
detected	detected	VBN	0
with	with	IN	0
Cry1Aa-binding	Cry1Aa-binding	CD	0
capability	capability	NN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
;	;	:	0
fractions	fractions	CD	0
33-36	33-36	CD	0
)	)	-RRB-	0
.	.	.	0
As	As	RB	0
expected	expected	VBN	0
,	,	,	0
fractions	fractions	NNS	0
were	were	VBD	0
also	also	RB	0
observed	observed	VBN	0
that	that	IN	0
exhibited	exhibited	VBG	0
no	no	DT	0
APN	APN	NNP	B-NP
enzymatic	enzymatic	JJ	I-NP
activity	activity	NN	I-NP
but	but	CC	0
bound	bound	JJ	0
Cry1Aa	Cry1Aa	NN	0
on	on	IN	0
slot	slot	NN	B-NP
blot	blot	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
;	;	:	0
fractions	fractions	CD	0
26-27	26-27	CD	0
)	)	-RRB-	0
.	.	.	0
Initially	Initially	RB	0
these	these	DT	0
fractions	fractions	NN	0
were	were	VBD	0
predicted	predicted	VBN	0
to	to	TO	0
contain	contain	VB	0
the	the	DT	0
cadherin-like	cadherin-like	JJ	0
Cry1Aa-binding	Cry1Aa-binding	CD	0
protein	protein	NN	0
[	[	-LRB-	0
13	13	CD	0
14	14	CD	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
candidate	candidate	NN	I-NP
receptor	receptor	NN	I-NP
fraction	fraction	NN	I-NP
and	and	CC	0
cadherin	cadherin	NN	B-NP
were	were	VBD	0
separately	separately	RB	0
loaded	loaded	VBN	0
on	on	IN	0
a	a	DT	0
size-exclusion	size-exclusion	JJ	B-NP
column	column	NN	I-NP
for	for	IN	0
further	further	JJ	0
purification	purification	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
2Aand	2Aand	CD	0
2B	2B	CD	0
)	)	-RRB-	0
.	.	.	0
A	A	DT	0
protein	protein	NN	B-NP
with	with	IN	0
APN	APN	NNP	B-NP
enzymatic	enzymatic	JJ	I-NP
activity	activity	NN	I-NP
eluted	eluted	VBD	0
75	75	CD	0
minutes	minutes	NNS	0
after	after	IN	0
injection	injection	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2A	2A	NNP	0
;	;	:	0
fractions	fractions	CD	0
15-16	15-16	CD	0
)	)	-RRB-	0
,	,	,	0
approximately	approximately	RB	0
4	4	CD	0
minutes	minutes	NNS	0
after	after	IN	0
the	the	DT	0
120-kDa	120-kDa	NNP	0
L.	L.	NNP	0
dispar	dispar	FW	0
APN	APN	FW	0
elutes	elutes	FW	0
on	on	IN	0
the	the	DT	0
same	same	JJ	0
column	column	NN	0
[	[	-LRB-	0
19	19	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
candidate	candidate	NN	B-NP
cadherin-like	cadherin-like	JJ	I-NP
receptor	receptor	NN	I-NP
fraction	fraction	NN	I-NP
eluted	eluted	NN	0
in	in	IN	0
fractions	fractions	CD	0
9-11	9-11	CD	0
at	at	IN	0
around	around	IN	0
180	180	CD	0
kDum	kDum	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2B	2B	NNP	0
)	)	-RRB-	0
.	.	.	0
Analysis	Analysis	NN	0
of	of	IN	0
receptor	receptor	NN	B-NP
purity	purity	VBD	I-NP
The	The	DT	0
pooled	pooled	NN	0
and	and	CC	0
concentrated	concentrated	JJ	0
candidate	candidate	NN	B-NP
receptor	receptor	NN	I-NP
fraction	fraction	NN	I-NP
were	were	VBD	0
examined	examined	VBN	0
by	by	IN	0
SDS-PAGE	SDS-PAGE	JJ	B-NP
before	before	IN	0
and	and	CC	0
after	after	IN	0
size-exclusion	size-exclusion	JJ	B-NP
purification	purification	NN	I-NP
to	to	TO	0
assess	assess	VB	0
purity	purity	NNS	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
putative	putative	JJ	B-NP
cadherin-like	cadherin-like	JJ	I-NP
receptor	receptor	NN	I-NP
material	material	NN	I-NP
appears	appears	VBZ	0
at	at	IN	0
a	a	DT	0
molecular	molecular	JJ	B-NP
size	size	NN	I-NP
around	around	IN	0
180	180	CD	0
kDa	kDa	NN	B-NP
,	,	,	0
both	both	DT	0
before	before	RB	0
and	and	CC	0
after	after	IN	0
secondary	secondary	JJ	B-NP
purification	purification	NN	I-NP
(	(	-LRB-	0
Lanes	Lanes	NNP	0
2	2	CD	0
and	and	CC	0
1	1	CD	0
,	,	,	0
respectively	respectively	RB	0
)	)	-RRB-	0
.	.	.	0
Several	Several	JJ	0
bbmv	bbmv	NN	B-NP
protein	protein	NN	I-NP
appear	appear	VBP	0
present	present	JJ	0
in	in	IN	0
the	the	DT	0
APN-containing	APN-containing	JJ	B-NP
fraction	fraction	NN	I-NP
prior	prior	RB	I-NP
to	to	TO	0
size-exclusion	size-exclusion	JJ	B-NP
purification	purification	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
;	;	:	0
Lane	Lane	NNP	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
molecular	molecular	JJ	B-NP
weight	weight	NN	I-NP
of	of	IN	0
the	the	DT	0
final	final	JJ	0
,	,	,	0
purified	purified	VBG	B-NP
APN	APN	NNP	I-NP
was	was	VBD	0
estimated	estimated	VBN	0
to	to	TO	0
be	be	VB	0
115-120	115-120	NNP	0
kDa	kDa	NNP	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
;	;	:	0
Lane	Lane	NNP	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
not	not	RB	0
known	known	VBN	0
whether	whether	IN	0
the	the	DT	0
GPI	GPI	NNP	B-NP
anchor	anchor	NN	I-NP
is	is	VBZ	0
still	still	RB	0
intact	intact	JJ	0
on	on	IN	0
the	the	DT	0
APN	APN	NNP	B-NP
receptor	receptor	NN	I-NP
;	;	:	0
however	however	RB	0
,	,	,	0
in	in	IN	0
the	the	DT	0
current	current	JJ	0
study	study	NN	0
,	,	,	0
phosphatidylinositol-specific	phosphatidylinositol-specific	JJ	B-NP
phospholipase	phospholipase	JJ	I-NP
C	C	NNP	0
(	(	-LRB-	0
phosphatidylinositol-specific	phosphatidylinositol-specific	NN	B-NP
phospholipase	phospholipase	NN	I-NP
c	c	NN	I-NP
)	)	-RRB-	0
was	was	VBD	0
not	not	RB	0
used	used	VBN	0
during	during	IN	0
BBMV	BBMV	NNP	B-NP
preparation	preparation	NN	I-NP
.	.	.	0
It	It	PRP	0
was	was	VBD	0
shown	shown	VBN	0
previously	previously	RB	0
that	that	IN	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
may	may	MD	0
be	be	VB	0
purified	purified	VBN	0
with	with	IN	0
intact	intact	JJ	0
gpi-anchor	gpi-anchor	NN	B-NP
if	if	IN	0
phosphatidylinositol	phosphatidylinositol	NN	B-NP
specific	specific	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
phospholipase	phospholipase	NN	I-NP
c	c	NN	I-NP
is	is	VBZ	0
omitted	omitted	VBN	0
from	from	IN	0
the	the	DT	0
preparation	preparation	NN	B-NP
buffer	buffer	NN	I-NP
[	[	-LRB-	0
6	6	CD	0
]	]	-RRB-	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
likely	likely	RB	0
that	that	IN	0
our	our	PRP$	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
has	has	VBZ	0
similarly	similarly	RB	0
retained	retained	VBD	0
the	the	DT	0
GPI	GPI	NNP	B-NP
anchor	anchor	NN	I-NP
.	.	.	0
In	In	IN	0
view	view	NN	0
of	of	IN	0
the	the	DT	0
fact	fact	NN	0
that	that	IN	0
B.	B.	NNP	0
mori	mori	FW	0
BtR175	BtR175	FW	0
possesses	possesses	FW	0
sequence	sequence	FW	0
similarity	similarity	FW	0
to	to	TO	0
M.	M.	NNP	0
sexta	sexta	VBD	0
BT-R	BT-R	JJ	0
1	1	CD	0
,	,	,	0
the	the	DT	0
candidate	candidate	NN	0
fraction	fraction	NN	0
was	was	VBD	0
probed	probed	VBN	0
on	on	IN	0
a	a	DT	0
slot	slot	NN	0
blot	blot	NN	0
with	with	IN	0
anti-BT-R	anti-BT-R	JJ	0
1	1	CD	0
polyclonal	polyclonal	CD	0
antiserum	antiserum	NNS	0
.	.	.	0
A	A	DT	0
weak	weak	JJ	0
to	to	TO	0
moderate	moderate	VB	0
cross-reactivity	cross-reactivity	JJ	0
with	with	IN	0
anti-BT-R	anti-BT-R	JJ	0
1	1	CD	0
was	was	VBD	0
observed	observed	VBN	0
for	for	IN	0
B.	B.	NNP	0
mori	mori	VBD	0
BBMV	BBMV	NNP	0
as	as	IN	0
well	well	RB	0
as	as	IN	0
the	the	DT	0
putative	putative	JJ	0
cadherin-like	cadherin-like	JJ	0
receptor	receptor	NN	0
fraction	fraction	NN	0
,	,	,	0
providing	providing	VBG	0
strong	strong	JJ	0
evidence	evidence	NN	0
that	that	IN	0
the	the	DT	0
material	material	NN	0
is	is	VBZ	0
a	a	DT	0
cadherin-like	cadherin-like	JJ	0
protein	protein	NN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
Anti-Bt-R	Anti-Bt-R	JJ	0
1	1	CD	0
antibody	antibody	NN	0
recognition	recognition	NN	0
was	was	VBD	0
not	not	RB	0
observed	observed	VBN	0
for	for	IN	0
fractions	fractions	JJ	0
eluting	eluting	NN	0
before	before	IN	0
and	and	CC	0
after	after	IN	0
the	the	DT	0
cadherin	cadherin	JJ	0
material	material	NN	0
,	,	,	0
nor	nor	CC	0
for	for	IN	0
the	the	DT	0
purified	purified	JJ	0
APN	APN	NNP	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
Similar	Similar	JJ	0
antibody	antibody	NN	0
assays	assays	NNS	0
were	were	VBD	0
not	not	RB	0
performed	performed	VBN	0
to	to	TO	0
substantiate	substantiate	VB	0
the	the	DT	0
identity	identity	NN	0
of	of	IN	0
the	the	DT	0
purified	purified	JJ	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
because	because	IN	0
it	it	PRP	0
clearly	clearly	RB	0
displayed	displayed	VBN	0
strong	strong	JJ	0
,	,	,	0
characteristic	characteristic	JJ	B-NP
APN	APN	NNP	I-NP
enzyme	enzyme	JJ	I-NP
activity	activity	NN	I-NP
.	.	.	0
The	The	DT	0
purity	purity	NN	0
of	of	IN	0
both	both	DT	0
receptor	receptor	NN	B-NP
was	was	VBD	0
further	further	RB	0
examined	examined	VBN	0
by	by	IN	0
a	a	DT	0
Cry1Aa	Cry1Aa	FW	0
toxin	toxin	FW	0
ligand	ligand	FW	0
blot	blot	FW	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
Both	Both	DT	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
and	and	CC	0
the	the	DT	0
cadherin-like	cadherin-like	JJ	B-NP
receptor	receptor	NN	I-NP
fraction	fraction	NN	I-NP
bound	bound	FW	0
biotinylated	biotinylated	FW	0
Cry1Aa	Cry1Aa	FW	0
.	.	.	0
No	No	DT	0
other	other	JJ	0
toxin-binding	toxin-binding	JJ	0
bands	bands	NNS	0
were	were	VBD	0
apparent	apparent	JJ	0
,	,	,	0
and	and	CC	0
neither	neither	DT	0
purified	purified	JJ	0
receptor	receptor	NN	B-NP
sample	sample	NN	I-NP
was	was	VBD	0
visibly	visibly	RB	0
cross-contaminated	cross-contaminated	JJ	0
with	with	IN	0
the	the	DT	0
other	other	JJ	0
receptor	receptor	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
Affinity	Affinity	JJ	0
estimation	estimation	NN	0
by	by	IN	0
surface	surface	FW	0
plasmon	plasmon	FW	0
resonance	resonance	FW	0
Cry	Cry	FW	0
toxin	toxin	FW	0
binding	binding	FW	0
studies	studies	NNS	0
have	have	VBP	0
been	been	VBN	0
reported	reported	VBN	0
previously	previously	RB	0
for	for	IN	0
B.	B.	NNP	0
mori	mori	NN	0
that	that	WDT	0
used	used	VBD	0
BBMV	BBMV	NNP	0
assays	assays	NN	0
or	or	CC	0
used	used	VBN	0
purified	purified	JJ	0
receptors	receptors	NNS	0
in	in	IN	0
ELISA	ELISA	NNP	0
assays	assays	NN	0
or	or	CC	0
blots	blots	NNS	0
;	;	:	0
however	however	RB	0
,	,	,	0
no	no	DT	0
Cry	Cry	JJ	0
toxin	toxin	NN	0
studies	studies	NNS	0
concerning	concerning	VBG	0
B.	B.	NNP	0
mori	mori	NNS	0
have	have	VBP	0
been	been	VBN	0
published	published	VBN	0
employing	employing	VBG	0
SPR	SPR	NNP	0
analysis	analysis	NN	0
.	.	.	0
The	The	DT	0
affinity	affinity	NN	0
of	of	IN	0
Cry1Aa	Cry1Aa	CD	0
binding	binding	NN	0
to	to	TO	0
B.	B.	NNP	0
mori	mori	VBD	0
APN	APN	NNP	0
and	and	CC	0
B.	B.	NNP	0
mori	mori	VBD	0
cadherin	cadherin	JJ	0
receptors	receptors	NNS	0
was	was	VBD	0
evaluated	evaluated	VBN	0
by	by	IN	0
real-time	real-time	JJ	0
kinetic	kinetic	JJ	0
analysis	analysis	NN	0
on	on	IN	0
a	a	DT	0
BIAcore	BIAcore	JJ	0
2000	2000	CD	0
.	.	.	0
Simple	Simple	JJ	0
bimolecular	bimolecular	JJ	0
binding	binding	NN	0
of	of	IN	0
Cry1Aa	Cry1Aa	NNP	0
was	was	VBD	0
observed	observed	VBN	0
to	to	TO	0
both	both	DT	0
B.	B.	NNP	0
mori	mori	VBD	0
APN	APN	NNP	0
and	and	CC	0
cadherin	cadherin	NNS	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
6Aand	6Aand	CD	0
6B	6B	CD	0
)	)	-RRB-	0
.	.	.	0
Toxin-receptor	Toxin-receptor	JJ	0
on-rates	on-rates	NN	0
for	for	IN	0
association	association	NN	0
(	(	-LRB-	0
k	k	FW	0
a	a	FW	0
)	)	-RRB-	0
,	,	,	0
off-rates	off-rates	JJ	0
for	for	IN	0
dissociation	dissociation	NNS	0
(	(	-LRB-	0
k	k	UH	0
d	d	LS	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
overall	overall	JJ	0
binding	binding	JJ	0
affinity	affinity	NNS	0
(	(	-LRB-	0
k	k	FW	0
d	d	FW	0
/	/	FW	0
k	k	FW	0
a	a	FW	0
,	,	,	0
or	or	CC	0
K	K	NNP	0
D	D	NNP	0
)	)	-RRB-	0
were	were	VBD	0
calculated	calculated	VBN	0
for	for	IN	0
toxin	toxin	NN	0
binding	binding	NN	0
.	.	.	0
The	The	DT	0
apparent	apparent	JJ	0
rate	rate	NN	0
constants	constants	NN	0
for	for	IN	0
wild-type	wild-type	NNP	0
Cry1Aa	Cry1Aa	NNP	0
and	and	CC	0
B.	B.	NNP	0
mori	mori	VBD	0
APN	APN	NNP	0
were	were	VBD	0
k	k	VBN	0
a	a	DT	0
=	=	CD	0
2.0	2.0	CD	0
×	×	CD	0
10	10	CD	0
4M	4M	CD	0
-1s	-1s	CD	0
-1	-1	CD	0
(	(	-LRB-	0
+	+	NNP	0
/	/	NNP	0
-	-	:	0
1.3	1.3	CD	0
×	×	CD	0
10	10	CD	0
2	2	CD	0
)	)	-RRB-	0
,	,	,	0
k	k	VBG	0
d	d	SYM	0
=	=	SYM	0
1.5	1.5	CD	0
×	×	CD	0
10	10	CD	0
-3s	-3s	CD	0
-1	-1	CD	0
(	(	-LRB-	0
+	+	NNP	0
/	/	NNP	0
-	-	:	0
1	1	CD	0
×	×	CD	0
10	10	CD	0
-5	-5	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
K	K	NNP	0
D	D	NNP	0
=	=	SYM	0
75	75	CD	0
nM	nM	NN	0
.	.	.	0
To	To	TO	0
B.	B.	NNP	0
mori	mori	JJ	0
cadherin	cadherin	NN	0
,	,	,	0
significantly	significantly	RB	0
tighter	tighter	JJR	0
affinities	affinities	NNS	0
were	were	VBD	0
obtained	obtained	VBN	0
:	:	:	0
k	k	VBG	0
a	a	DT	0
=	=	CD	0
1.3	1.3	CD	0
×	×	CD	0
10	10	CD	0
4M	4M	CD	0
-1s	-1s	CD	0
-1	-1	CD	0
(	(	-LRB-	0
+	+	NNP	0
/	/	NNP	0
-	-	:	0
6.1	6.1	CD	0
)	)	-RRB-	0
,	,	,	0
k	k	VBG	0
d	d	SYM	0
=	=	SYM	0
3.3	3.3	CD	0
×	×	CD	0
10	10	CD	0
-5s	-5s	CD	0
-1	-1	CD	0
(	(	-LRB-	0
+	+	NNP	0
/	/	NNP	0
-	-	:	0
1	1	CD	0
×	×	CD	0
10	10	CD	0
-5	-5	CD	0
)	)	-RRB-	0
,	,	,	0
K	K	NNP	0
D	D	NNP	0
=	=	SYM	0
2.6	2.6	CD	0
nM	nM	NN	0
.	.	.	0
This	This	DT	0
apparent	apparent	JJ	0
off-rate	off-rate	NN	0
clearly	clearly	RB	0
accounted	accounted	VBN	0
for	for	IN	0
Cry1Aa	Cry1Aa	NNP	0
's	's	POS	0
higher	higher	JJR	0
affinity	affinity	NN	0
for	for	IN	0
cadherin	cadherin	NN	0
than	than	IN	0
for	for	IN	0
APN	APN	NNP	0
.	.	.	0
The	The	DT	0
cadherin	cadherin	JJ	0
off-rate	off-rate	NN	0
observed	observed	VBD	0
in	in	IN	0
this	this	DT	0
study	study	NN	0
could	could	MD	0
have	have	VB	0
significant	significant	JJ	0
consequences	consequences	NNS	0
in	in	IN	0
vivo	vivo	NNS	0
:	:	:	0
slow	slow	JJ	0
toxin	toxin	NN	B-NP
dissociation	dissociation	NN	I-NP
may	may	MD	0
enable	enable	VB	0
protracted	protracted	JJ	0
lingering	lingering	NN	0
near	near	IN	0
the	the	DT	0
brush	brush	JJ	B-NP
border	border	NN	I-NP
membrane	membrane	NN	I-NP
surface	surface	NN	I-NP
,	,	,	0
greatly	greatly	RB	0
facilitating	facilitating	VBG	0
toxic	toxic	JJ	B-NP
(	(	-LRB-	0
domain	domain	NN	0
I	I	PRP	0
)	)	-RRB-	0
insertion	insertion	NN	0
and	and	CC	0
subsequent	subsequent	JJ	0
pore	pore	JJ	0
formation	formation	NN	0
.	.	.	0
The	The	DT	0
overall	overall	JJ	0
affinity	affinity	NN	B-NP
determined	determined	VBN	0
in	in	IN	0
the	the	DT	0
present	present	JJ	0
study	study	NN	0
for	for	IN	0
Cry1Aa	Cry1Aa	CD	0
to	to	TO	0
BtR175	BtR175	CD	B-NP
(	(	-LRB-	0
2.6	2.6	CD	0
nM	nM	NN	B-NP
)	)	-RRB-	0
agrees	agrees	VBZ	0
well	well	RB	0
with	with	IN	0
the	the	DT	0
findings	findings	NNS	0
of	of	IN	0
Ihara	Ihara	NNP	B-NP
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
16	16	CD	0
]	]	-RRB-	0
by	by	IN	0
a	a	DT	0
different	different	JJ	0
assay	assay	NN	B-NP
(	(	-LRB-	0
0.8	0.8	NNP	0
nM	nM	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
We	We	PRP	0
also	also	RB	0
explored	explored	VB	0
the	the	DT	0
specificity	specificity	NN	0
of	of	IN	0
Cry1Aa	Cry1Aa	CD	0
for	for	IN	0
the	the	DT	0
native	native	JJ	0
b.	b.	NN	B-NP
mori	mori	NN	I-NP
receptor	receptor	NN	I-NP
by	by	IN	0
comparing	comparing	VBG	0
the	the	DT	0
binding	binding	JJ	0
response	response	NN	0
of	of	IN	0
Cry1Aa	Cry1Aa	CD	0
with	with	IN	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
Cry1Ab	Cry1Ab	NNP	0
,	,	,	0
Cry1Ac	Cry1Ac	NNP	0
,	,	,	0
and	and	CC	0
domain-switched	domain-switched	JJ	B-NP
toxin	toxin	NN	I-NP
4109	4109	CD	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
7Aand	7Aand	CD	0
7B	7B	CD	0
)	)	-RRB-	0
.	.	.	0
Hybrid	Hybrid	JJ	B-NP
toxin	toxin	NN	I-NP
4109	4109	CD	0
is	is	VBZ	0
particular	particular	JJ	0
useful	useful	JJ	0
in	in	IN	0
this	this	DT	0
context	context	NN	0
,	,	,	0
because	because	IN	0
it	it	PRP	0
is	is	VBZ	0
comprised	comprised	VBN	0
of	of	IN	0
domains	domains	VBG	0
I	I	PRP	0
and	and	CC	0
II	II	NNP	0
from	from	IN	0
Cry1Aa	Cry1Aa	NNP	0
and	and	CC	0
domain	domain	JJ	0
III	III	NNP	0
from	from	IN	0
Cry1Ac	Cry1Ac	NNP	0
(	(	-LRB-	0
Aa	Aa	NNP	B-NP
/	/	NNP	I-NP
Aa	Aa	NNP	I-NP
/	/	NNP	I-NP
Ac	Ac	NNP	I-NP
)	)	-RRB-	0
[	[	-LRB-	0
3	3	LS	0
]	]	-RRB-	0
.	.	.	0
Hybrid-toxin	Hybrid-toxin	JJ	0
4109	4109	CD	0
binding	binding	NN	0
to	to	TO	0
both	both	DT	0
receptors	receptors	NN	0
was	was	VBD	0
not	not	RB	0
noticeably	noticeably	RB	0
different	different	JJ	0
from	from	IN	0
Cry1Aa	Cry1Aa	CD	0
:	:	:	0
for	for	IN	0
APN	APN	NNP	0
binding	binding	NN	0
,	,	,	0
k	k	VBG	0
a	a	DT	0
=	=	CD	0
1.9	1.9	CD	0
×	×	CD	0
10	10	CD	0
4M	4M	CD	0
-1s	-1s	CD	0
-1	-1	CD	0
(	(	-LRB-	0
+	+	NNP	0
/	/	NNP	0
-	-	:	0
1.4	1.4	CD	0
×	×	CD	0
10	10	CD	0
2	2	CD	0
)	)	-RRB-	0
,	,	,	0
k	k	VBG	0
d	d	SYM	0
=	=	SYM	0
1.5	1.5	CD	0
×	×	CD	0
10	10	CD	0
-3s	-3s	CD	0
-1	-1	CD	0
(	(	-LRB-	0
+	+	NNP	0
/	/	NNP	0
-	-	:	0
1.6	1.6	CD	0
×	×	CD	0
10	10	CD	0
-5	-5	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
K	K	NNP	0
D	D	NNP	0
=	=	SYM	0
78	78	CD	0
nM	nM	NN	0
;	;	:	0
for	for	IN	0
cadherin	cadherin	JJ	0
binding	binding	NN	0
,	,	,	0
k	k	VBG	0
a	a	DT	0
=	=	CD	0
1.3	1.3	CD	0
×	×	CD	0
10	10	CD	0
4M	4M	CD	0
-1s	-1s	CD	0
-1	-1	CD	0
(	(	-LRB-	0
+	+	NNP	0
/	/	NNP	0
-	-	:	0
2	2	CD	0
×	×	CD	0
10	10	CD	0
2	2	CD	0
)	)	-RRB-	0
,	,	,	0
k	k	VBG	0
d	d	SYM	0
=	=	SYM	0
3.34	3.34	CD	0
×	×	CD	0
10	10	CD	0
-5s	-5s	CD	0
-1	-1	CD	0
(	(	-LRB-	0
+	+	NNP	0
/	/	NNP	0
-	-	:	0
2	2	CD	0
×	×	CD	0
10	10	CD	0
-5	-5	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
K	K	NNP	0
D	D	NNP	0
=	=	SYM	0
2.6	2.6	CD	0
nM	nM	NN	0
.	.	.	0
In	In	IN	0
stark	stark	JJ	0
contrast	contrast	NN	0
,	,	,	0
Cry1Ab	Cry1Ab	NNP	0
and	and	CC	0
Cry1Ac	Cry1Ac	NNP	0
showed	showed	VBD	0
no	no	DT	0
apparent	apparent	JJ	0
binding	binding	NN	0
to	to	TO	0
either	either	DT	0
receptor	receptor	NN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
7Aand	7Aand	CD	0
7B	7B	CD	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
are	are	VBP	0
entirely	entirely	RB	0
consistent	consistent	JJ	0
with	with	IN	0
the	the	DT	0
hypothesis	hypothesis	NN	0
that	that	IN	0
Cry1Aa	Cry1Aa	CD	0
domain	domain	NN	0
II	II	NNP	0
(	(	-LRB-	0
alone	alone	RB	0
)	)	-RRB-	0
is	is	VBZ	0
essential	essential	JJ	0
for	for	IN	0
binding	binding	VBG	0
to	to	TO	0
both	both	PDT	0
the	the	DT	0
APN	APN	NNP	0
and	and	CC	0
cadherin-like	cadherin-like	JJ	0
receptors	receptors	NNS	0
as	as	IN	0
purified	purified	NN	0
in	in	IN	0
the	the	DT	0
present	present	JJ	0
study	study	NN	0
.	.	.	0
Discussion	Discussion	NN	0
The	The	DT	0
dissociation	dissociation	JJ	B-NP
constant	constant	JJ	I-NP
presented	presented	NNS	0
are	are	VBP	0
the	the	DT	0
first	first	JJ	0
determined	determined	VBN	0
for	for	IN	0
b.	b.	NN	B-NP
mori	mori	NNP	I-NP
cry	cry	NN	I-NP
receptor	receptor	NN	I-NP
by	by	IN	0
the	the	DT	0
use	use	NN	0
of	of	IN	0
SPR	SPR	NNP	B-NP
technology	technology	NN	I-NP
.	.	.	0
Additionally	Additionally	RB	0
,	,	,	0
the	the	DT	0
apparent	apparent	JJ	0
affinity	affinity	NN	B-NP
of	of	IN	0
Cry1Aa	Cry1Aa	CD	0
for	for	IN	0
the	the	DT	0
cadherin-like	cadherin-like	JJ	B-NP
receptor	receptor	NN	I-NP
is	is	VBZ	0
the	the	DT	0
highest	highest	JJS	0
observed	observed	JJ	0
affinity	affinity	NN	B-NP
to	to	TO	0
date	date	NN	0
for	for	IN	0
Cry	Cry	NNP	B-NP
toxin	toxin	NN	I-NP
binding	binding	VBG	0
to	to	TO	0
purified	purified	VB	0
receptors	receptors	VBN	0
using	using	VBG	0
SPR	SPR	NNP	B-NP
.	.	.	0
This	This	DT	0
finding	finding	NN	0
emphasizes	emphasizes	VBZ	0
the	the	DT	0
important	important	JJ	0
biological	biological	JJ	B-NP
role	role	NN	I-NP
that	that	IN	0
this	this	DT	0
receptor	receptor	NN	B-NP
class	class	NN	I-NP
plays	plays	VBZ	0
for	for	IN	0
bt	bt	NN	B-NP
toxin	toxin	NN	I-NP
.	.	.	0
Recently	Recently	RB	0
,	,	,	0
using	using	VBG	0
phage	phage	JJ	B-NP
display	display	NN	I-NP
technology	technology	NN	I-NP
,	,	,	0
a	a	DT	0
scFv	scFv	JJ	B-NP
molecule	molecule	NN	I-NP
with	with	IN	0
short	short	JJ	0
sequence	sequence	NN	B-NP
homology	homology	NN	I-NP
to	to	TO	0
M.	M.	NNP	B-NP
sexta	sexta	NN	I-NP
and	and	CC	0
b.	b.	NN	B-NP
mori	mori	VBD	I-NP
cadherin-like	cadherin-like	JJ	I-NP
receptor	receptor	NN	I-NP
was	was	VBD	0
shown	shown	VBN	0
to	to	TO	0
bind	bind	VB	0
domain	domain	JJ	0
II	II	NNP	0
of	of	IN	0
Cry1Aa	Cry1Aa	NNP	0
,	,	,	0
Cry1Ab	Cry1Ab	NNP	0
,	,	,	0
and	and	CC	0
Cry1Ac	Cry1Ac	CD	0
toxins	toxins	NNS	0
[	[	-LRB-	0
20	20	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
the	the	DT	0
present	present	JJ	0
study	study	NN	0
,	,	,	0
only	only	RB	0
Cry1Aa	Cry1Aa	CD	0
shows	shows	NNS	0
measurable	measurable	VBP	0
binding	binding	VBG	0
to	to	TO	0
the	the	DT	0
purified	purified	NN	0
,	,	,	0
native	native	JJ	0
cadherin-like	cadherin-like	JJ	B-NP
receptor	receptor	NN	I-NP
from	from	IN	0
B.	B.	NNP	B-NP
mori	mori	NN	I-NP
.	.	.	0
This	This	DT	0
finding	finding	NN	0
may	may	MD	0
be	be	VB	0
the	the	DT	0
result	result	NN	0
of	of	IN	0
purification	purification	NN	B-NP
of	of	IN	0
a	a	DT	0
particular	particular	JJ	0
receptor	receptor	NN	B-NP
variant	variant	NN	I-NP
with	with	IN	0
Cry1Aa	Cry1Aa	CD	0
specificity	specificity	NNS	0
(	(	-LRB-	0
e.g.	e.g.	NNP	0
,	,	,	0
one	one	CD	0
of	of	IN	0
potentially	potentially	RB	0
several	several	JJ	0
glycosylated	glycosylated	JJ	B-NP
isoform	isoform	NN	I-NP
)	)	-RRB-	0
.	.	.	0
Alternatively	Alternatively	RB	0
,	,	,	0
it	it	PRP	0
may	may	MD	0
reflect	reflect	VB	0
greater	greater	JJR	0
specificity	specificity	NN	0
of	of	IN	0
Cry1Aa	Cry1Aa	CD	0
domain	domain	NN	0
II	II	NNP	0
for	for	IN	0
neighboring	neighboring	JJ	0
residues	residues	NNS	0
on	on	IN	0
the	the	DT	0
B.	B.	NNP	B-NP
mori	mori	VBD	I-NP
cadherin-like	cadherin-like	JJ	I-NP
receptor	receptor	NN	I-NP
beyond	beyond	IN	0
the	the	DT	0
conserved	conserved	JJ	0
Cry1A-toxin	Cry1A-toxin	CD	0
binding	binding	JJ	0
segment	segment	NN	0
,	,	,	0
which	which	WDT	0
might	might	MD	0
be	be	VB	0
absent	absent	VBN	0
in	in	IN	0
smaller	smaller	JJR	0
peptide	peptide	JJ	B-NP
sequence	sequence	NN	I-NP
.	.	.	0
The	The	DT	0
apparent	apparent	JJ	0
Cry1Aa	Cry1Aa	CD	0
affinity	affinity	NN	0
for	for	IN	0
purified	purified	JJ	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
measured	measured	VBN	0
in	in	IN	0
this	this	DT	0
study	study	NN	0
,	,	,	0
75	75	CD	0
nM	nM	NN	B-NP
,	,	,	0
is	is	VBZ	0
10-fold	10-fold	JJ	0
higher	higher	JJR	0
than	than	IN	0
the	the	DT	0
value	value	NN	0
reported	reported	VBD	0
by	by	IN	0
Yaoi	Yaoi	NNP	B-NP
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
6	6	CD	0
]	]	-RRB-	0
for	for	IN	0
purified	purified	JJ	0
110-kDa	110-kDa	NNP	0
APN	APN	NNP	0
using	using	VBG	0
a	a	DT	0
separate	separate	JJ	0
technique	technique	NN	0
(	(	-LRB-	0
7.6	7.6	CD	0
nM	nM	NN	B-NP
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
the	the	DT	0
aforementioned	aforementioned	JJ	B-NP
study	study	NN	I-NP
,	,	,	0
an	an	DT	0
ELISA	ELISA	NNP	B-NP
assay	assay	NN	I-NP
was	was	VBD	0
used	used	VBN	0
to	to	TO	0
indirectly	indirectly	RB	0
calculate	calculate	VB	0
affinity	affinity	VBN	B-NP
by	by	IN	0
incubating	incubating	JJ	0
receptor-bound	receptor-bound	JJ	B-NP
toxin	toxin	NN	I-NP
with	with	IN	0
a	a	DT	0
peroxidase-conjugated	peroxidase-conjugated	JJ	0
anti-Cry1Aa	anti-Cry1Aa	CD	0
antibody	antibody	NN	0
over	over	IN	0
1.5	1.5	CD	0
hours	hours	NNS	0
at	at	IN	0
37°C	37°C	CD	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
possible	possible	JJ	0
that	that	IN	0
the	the	DT	0
difference	difference	NN	0
in	in	IN	0
binding	binding	JJ	0
constants	constants	NN	0
reflects	reflects	VBZ	0
our	our	PRP$	0
condition	condition	NN	0
of	of	IN	0
more	more	RBR	0
direct	direct	JJ	0
receptor-binding	receptor-binding	JJ	B-NP
measurement	measurement	NN	I-NP
in	in	IN	0
"real-time	"real-time	NNP	0
"	"	''	0
,	,	,	0
as	as	RB	0
well	well	RB	0
as	as	IN	0
the	the	DT	0
different	different	JJ	0
binding	binding	JJ	0
buffers	buffers	NN	0
and	and	CC	0
temperature	temperature	NN	0
used	used	VBN	0
.	.	.	0
Yaoi	Yaoi	NN	B-NP
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
21	21	CD	0
]	]	-RRB-	0
estimated	estimated	VBD	0
the	the	DT	0
toxin-binding	toxin-binding	JJ	0
region	region	NN	0
of	of	IN	0
B.	B.	NNP	B-NP
mori	mori	VBD	I-NP
APN	APN	NNP	I-NP
to	to	TO	0
be	be	VB	0
between	between	IN	0
Ile135	Ile135	NNP	B-NP
and	and	CC	0
Pro198	Pro198	RB	0
based	based	VBN	0
on	on	IN	0
toxin	toxin	NN	B-NP
blot	blot	NN	I-NP
overlay	overlay	NN	I-NP
with	with	IN	0
protease-digested	protease-digested	NNP	B-NP
apn	apn	NN	I-NP
fragment	fragment	NN	I-NP
.	.	.	0
blast	blast	NN	B-NP
sequence	sequence	NN	I-NP
alignment	alignment	NN	I-NP
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
yielded	yielded	VBD	0
81	81	CD	0
%	%	NN	0
identity	identity	NN	0
and	and	CC	0
96	96	CD	0
%	%	NN	0
similarity	similarity	NN	0
between	between	IN	0
this	this	DT	0
63	63	CD	0
residue	residue	JJ	0
stretch	stretch	NN	0
and	and	CC	0
the	the	DT	0
homologous	homologous	JJ	B-NP
region	region	NN	I-NP
of	of	IN	0
M.	M.	NNP	0
sexta	sexta	VBD	0
APN-1	APN-1	CD	B-NP
,	,	,	0
which	which	WDT	0
also	also	RB	0
binds	binds	CD	0
Cry1Aa	Cry1Aa	CD	0
toxin	toxin	NN	0
(	(	-LRB-	0
Jenkins	Jenkins	NNP	0
,	,	,	0
unpublished	unpublished	JJ	0
observation	observation	NN	0
)	)	-RRB-	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
in	in	IN	0
L.	L.	NNP	0
dispar	dispar	VBD	0
APN-1	APN-1	CD	B-NP
,	,	,	0
which	which	WDT	0
does	does	VBZ	0
not	not	RB	0
bind	bind	CD	0
Cry1Aa	Cry1Aa	CD	0
,	,	,	0
the	the	DT	0
same	same	JJ	0
stretch	stretch	NN	0
is	is	VBZ	0
only	only	RB	0
37	37	CD	0
%	%	NN	0
identical	identical	NNS	0
and	and	CC	0
56	56	CD	0
%	%	NN	0
similar	similar	JJ	0
(	(	-LRB-	0
4	4	CD	0
%	%	NN	0
unaligned	unaligned	NN	B-NP
gap	gap	NN	I-NP
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
appear	appear	VBP	0
to	to	TO	0
support	support	VB	0
the	the	DT	0
findings	findings	NNS	0
of	of	IN	0
Yaoi	Yaoi	NNP	B-NP
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
heliothi	heliothi	NN	B-NP
virescen	virescen	NN	I-NP
(	(	-LRB-	0
tobacco	tobacco	NN	B-NP
budworm	budworm	NN	I-NP
)	)	-RRB-	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
is	is	VBZ	0
only	only	RB	0
45	45	CD	0
%	%	NN	0
identical	identical	NNS	0
and	and	CC	0
53	53	CD	0
%	%	NN	0
similar	similar	JJ	0
to	to	TO	0
B.	B.	NNP	B-NP
mori	mori	VBD	I-NP
APN	APN	NNP	I-NP
,	,	,	0
yet	yet	RB	0
it	it	PRP	0
binds	binds	VBD	0
Cry1Aa	Cry1Aa	CD	0
toxin	toxin	NN	0
with	with	IN	0
high	high	JJ	0
affinity	affinity	NN	B-NP
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
Moreover	Moreover	RB	0
,	,	,	0
sequence	sequence	JJ	B-NP
alignment	alignment	NN	I-NP
with	with	IN	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
from	from	IN	0
Lactobacillus	Lactobacillus	NNP	B-NP
,	,	,	0
Streptococcus	Streptococcus	NNP	0
,	,	,	0
saccharomyce	saccharomyce	NN	B-NP
,	,	,	0
arabidopsi	arabidopsi	NN	B-NP
,	,	,	0
rat	rat	NN	0
,	,	,	0
pig	pig	NN	0
,	,	,	0
yeast	yeast	NN	0
,	,	,	0
and	and	CC	0
human	human	JJ	0
yielded	yielded	NN	0
more	more	JJR	0
similarity	similarity	NN	0
than	than	IN	0
H.	H.	NNP	0
virescens	virescens	VBD	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
to	to	TO	0
the	the	DT	0
putative	putative	JJ	0
Cry1Aa-binding	Cry1Aa-binding	CD	0
region	region	NN	0
of	of	IN	0
B.	B.	NNP	B-NP
mori	mori	VBD	I-NP
APN	APN	NNP	I-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
likely	likely	RB	0
that	that	IN	0
as	as	IN	0
the	the	DT	0
apn	apn	NN	B-NP
x-ray	x-ray	NN	I-NP
crystal	crystal	NN	I-NP
structure	structure	NN	I-NP
are	are	VBP	0
solved	solved	VBN	0
,	,	,	0
apn	apn	NN	B-NP
structural	structural	JJ	I-NP
alignment	alignment	NN	I-NP
will	will	MD	0
help	help	VB	0
resolve	resolve	VB	0
the	the	DT	0
specificity-determining	specificity-determining	JJ	0
regions	regions	NNS	0
more	more	RBR	0
accurately	accurately	RB	0
.	.	.	0
Additionally	Additionally	RB	0
,	,	,	0
structural	structural	JJ	B-NP
information	information	NN	I-NP
will	will	MD	0
aid	aid	VB	0
in	in	IN	0
the	the	DT	0
rational	rational	JJ	B-NP
construction	construction	NN	I-NP
of	of	IN	0
toxins	toxins	NN	0
with	with	IN	0
reduced	reduced	JJ	0
binding	binding	NN	0
for	for	IN	0
beneficial	beneficial	JJ	0
insects	insects	NNS	0
without	without	IN	0
losing	losing	VBG	B-NP
activity	activity	NN	I-NP
to	to	TO	0
target	target	VB	0
pests	pests	NNS	0
.	.	.	0
In	In	IN	0
this	this	DT	0
context	context	NN	0
a	a	DT	0
unique	unique	JJ	0
Cry1Aa	Cry1Aa	FW	0
binding	binding	JJ	B-NP
epitope	epitope	NN	I-NP
within	within	FW	0
domain	domain	FW	0
II	II	NNP	0
has	has	VBZ	0
been	been	VBN	0
identified	identified	VBN	0
that	that	IN	0
,	,	,	0
when	when	WRB	0
mutated	mutated	NNS	0
,	,	,	0
results	results	NNS	0
in	in	IN	0
specific	specific	JJ	0
reduction	reduction	NN	0
of	of	IN	0
toxicity	toxicity	VBG	0
to	to	TO	0
B.	B.	NNP	B-NP
mus	mus	NN	I-NP
(	(	-LRB-	0
You	You	PRP	0
,	,	,	0
et	et	FW	0
al.	al.	FW	0
,	,	,	0
unpublished	unpublished	JJ	0
manuscript	manuscript	NN	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
application	application	NN	0
of	of	IN	0
protein	protein	NN	0
engineering	engineering	NN	0
to	to	TO	0
b.	b.	NN	B-NP
thuringiensis	thuringiensis	NNS	I-NP
insecticidal	insecticidal	NN	I-NP
protein	protein	NN	I-NP
is	is	VBZ	0
entering	entering	VBG	0
a	a	DT	0
new	new	JJ	0
era	era	NN	0
of	of	IN	0
tailoring	tailoring	JJ	0
pesticides	pesticides	NNS	0
with	with	IN	0
reduced	reduced	JJ	0
activity	activity	NN	0
to	to	TO	0
beneficial	beneficial	JJ	0
insects	insects	NNS	0
as	as	IN	0
well	well	RB	0
as	as	IN	0
increasing	increasing	VBG	B-NP
activity	activity	NN	I-NP
against	against	IN	0
pest	pest	JJ	0
insects	insects	NNS	0
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
Conclusions	Conclusions	NNP	B-NP
Domain	Domain	NNP	I-NP
II	II	NNP	I-NP
of	of	IN	0
Cry1Aa	Cry1Aa	NNP	0
is	is	VBZ	0
both	both	DT	0
necessary	necessary	JJ	0
and	and	CC	0
essential	essential	JJ	0
for	for	IN	0
tight	tight	JJ	0
binding	binding	NN	0
to	to	TO	0
two	two	CD	0
b.	b.	NN	B-NP
mori	mori	NNP	I-NP
midgut	midgut	NN	I-NP
receptor	receptor	NN	I-NP
,	,	,	0
the	the	DT	0
cadherin-like	cadherin-like	JJ	B-NP
and	and	CC	0
aminopeptidase	aminopeptidase	JJ	B-NP
n	n	NN	I-NP
receptor	receptor	NN	I-NP
,	,	,	0
a	a	DT	0
finding	finding	NN	0
that	that	IN	0
correlates	correlates	NN	0
with	with	IN	0
biological	biological	JJ	B-NP
activity	activity	NN	I-NP
data	data	NN	I-NP
.	.	.	0
The	The	DT	0
Cry1Aa	Cry1Aa	JJ	0
binding	binding	JJ	0
affinity	affinity	NN	0
,	,	,	0
as	as	RB	0
well	well	RB	0
as	as	IN	0
the	the	DT	0
cadherin-like	cadherin-like	JJ	B-NP
receptor	receptor	NN	I-NP
dissociation	dissociation	JJ	I-NP
rate	rate	NN	I-NP
,	,	,	0
are	are	VBP	0
the	the	DT	0
lowest	lowest	JJS	0
measured	measured	VBN	0
using	using	VBG	0
the	the	DT	0
surface	surface	NN	B-NP
plasmon	plasmon	NN	I-NP
resonance	resonance	NN	I-NP
technique	technique	NN	I-NP
.	.	.	0
The	The	DT	0
SPR	SPR	NNP	B-NP
method	method	NN	I-NP
presented	presented	VBD	0
here	here	RB	0
may	may	MD	0
be	be	VB	0
useful	useful	JJ	0
for	for	IN	0
screening	screening	VBG	0
other	other	JJ	0
cry	cry	NN	B-NP
toxin	toxin	NN	I-NP
or	or	CC	0
cry	cry	NN	B-NP
toxin	toxin	NN	I-NP
variant	variant	JJ	I-NP
specifically	specifically	RB	0
engineered	engineered	VBN	0
to	to	TO	0
reduce	reduce	VB	0
or	or	CC	0
eliminate	eliminate	VB	0
specificity	specificity	VBN	0
for	for	IN	0
receptor	receptor	NN	B-NP
from	from	IN	0
this	this	DT	0
non-target	non-target	JJ	B-NP
insect	insect	NN	I-NP
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
methods	methods	NNS	0
Mutant	Mutant	JJ	B-NP
toxin	toxin	NN	I-NP
construction	construction	NN	I-NP
and	and	CC	0
preliminary	preliminary	JJ	B-NP
analysis	analysis	NN	I-NP
Hybrid	Hybrid	NNP	I-NP
toxin	toxin	NN	I-NP
4109	4109	CD	0
consisting	consisting	NN	0
of	of	IN	0
domains	domains	VBG	0
I	I	PRP	0
and	and	CC	0
II	II	NNP	0
of	of	IN	0
Cry1Aa	Cry1Aa	NNP	0
and	and	CC	0
domain	domain	JJ	0
III	III	NNP	0
of	of	IN	0
Cry1Ac	Cry1Ac	NNP	0
was	was	VBD	0
constructed	constructed	VBN	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
3	3	LS	0
]	]	-RRB-	0
.	.	.	0
Force-feeding	Force-feeding	JJ	0
bioassay	bioassay	NN	B-NP
on	on	IN	0
B.	B.	NNP	B-NP
mori	mori	NN	I-NP
and	and	CC	0
BBMV	BBMV	NNP	B-NP
binding	binding	JJ	0
assays	assays	NN	0
were	were	VBD	0
conducted	conducted	VBN	0
as	as	RB	0
described	described	VBN	0
[	[	-LRB-	0
4	4	LS	0
]	]	-RRB-	0
.	.	.	0
Crystal	Crystal	NN	0
proteins	proteins	NNS	0
were	were	VBD	0
solubilized	solubilized	JJ	0
and	and	CC	0
trypsinized	trypsinized	NN	0
,	,	,	0
and	and	CC	0
active	active	JJ	0
toxins	toxins	NN	0
were	were	VBD	0
column	column	NN	0
purified	purified	VBZ	0
as	as	RB	0
carried	carried	VBN	0
out	out	RP	0
previously	previously	RB	0
[	[	-LRB-	0
19	19	CD	0
]	]	-RRB-	0
.	.	.	0
Receptor	Receptor	NNP	0
purification	purification	VBD	0
B.	B.	NNP	0
mori	mori	NN	0
midguts	midguts	NNS	0
were	were	VBD	0
dissected	dissected	VBN	0
from	from	IN	0
4	4	CD	0
thor	thor	CD	0
5	5	CD	0
thinstar	thinstar	CD	0
larvae	larvae	NNS	0
and	and	CC	0
brush	brush	JJ	0
border	border	NN	0
membrane	membrane	NN	0
vesicles	vesicles	NNS	0
were	were	VBD	0
prepared	prepared	VBN	0
by	by	IN	0
the	the	DT	0
Wolfersberger	Wolfersberger	JJ	0
method	method	NN	0
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
B.	B.	NNP	B-NP
mori	mori	NNP	I-NP
BBMV	BBMV	NN	I-NP
(	(	-LRB-	0
10	10	CD	0
mg	mg	NN	B-NP
in	in	IN	0
10	10	CD	0
ml	ml	CD	0
)	)	-RRB-	0
was	was	VBD	0
solubilized	solubilized	VBN	0
in	in	IN	0
5	5	CD	0
zwitterionic	zwitterionic	NN	B-NP
detergent	detergent	JJ	I-NP
mg/ml	mg/ml	NN	I-NP
chap	chap	NN	I-NP
(	(	-LRB-	0
Roche	Roche	NNP	0
)	)	-RRB-	0
overnight	overnight	JJ	0
at	at	IN	0
4	4	CD	0
oC	oC	NN	B-NP
with	with	IN	0
gentle	gentle	JJ	0
rocking	rocking	NN	0
.	.	.	0
Solubilized	Solubilized	NNP	0
BBMV	BBMV	NNP	B-NP
was	was	VBD	0
centrifuged	centrifuged	VBN	0
at	at	IN	0
10,000	10,000	CD	0
×	×	CD	0
g	g	NN	0
for	for	IN	0
10	10	CD	0
min	min	NN	B-NP
and	and	CC	0
supernatant	supernatant	NN	B-NP
was	was	VBD	0
concentrated	concentrated	VBN	0
to	to	TO	0
2	2	CD	0
ml	ml	NN	0
by	by	IN	0
Amicon	Amicon	NNP	B-NP
YM30	YM30	NNP	I-NP
ultrafiltration	ultrafiltration	NN	I-NP
.	.	.	0
The	The	DT	0
sample	sample	NN	0
was	was	VBD	0
then	then	RB	0
loaded	loaded	VBN	0
on	on	IN	0
a	a	DT	0
Q	Q	NNP	B-NP
Sepharose	Sepharose	NNP	I-NP
HR	HR	NNP	I-NP
10	10	CD	0
/	/	CD	0
30	30	CD	0
anion-exchange	anion-exchange	JJ	B-NP
column	column	NN	I-NP
.	.	.	0
All	All	DT	0
column	column	NN	B-NP
chromatography	chromatography	NN	I-NP
was	was	VBD	0
carried	carried	VBN	0
out	out	RP	0
on	on	IN	0
an	an	DT	0
ÄKTA	ÄKTA	NNP	B-NP
Explorer	Explorer	NNP	I-NP
(	(	-LRB-	0
Amersham	Amersham	NNP	B-NP
Pharmacia	Pharmacia	NNP	I-NP
Biotech	Biotech	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
Low	Low	JJ	B-NP
salt	salt	NN	I-NP
buffer	buffer	NN	I-NP
(	(	-LRB-	0
buffer	buffer	VB	B-NP
A	A	DT	0
)	)	-RRB-	0
consisted	consisted	VBD	0
of	of	IN	0
20	20	CD	0
mm	mm	NN	B-NP
tri	tri	NNP	I-NP
,	,	,	0
5	5	CD	0
mM	mM	JJ	B-NP
MgCl	MgCl	NN	I-NP
,	,	,	0
0.4	0.4	CD	0
mg/ml	mg/ml	NN	B-NP
chap	chap	NN	I-NP
,	,	,	0
pH	pH	JJ	0
8.6	8.6	CD	0
,	,	,	0
and	and	CC	0
the	the	DT	0
high	high	JJ	0
salt	salt	NN	B-NP
buffer	buffer	NN	I-NP
used	used	VBN	0
was	was	VBD	0
buffer	buffer	VBN	B-NP
A	A	DT	0
containing	containing	VBG	0
1	1	CD	0
M	M	NNP	0
NaCl	NaCl	NNP	B-NP
.	.	.	0
A	A	DT	0
salt	salt	NN	B-NP
step	step	NN	I-NP
gradient	gradient	NN	I-NP
was	was	VBD	0
used	used	VBN	0
to	to	TO	0
elute	elute	VB	0
bbmv	bbmv	NN	B-NP
protein	protein	NN	I-NP
.	.	.	0
All	All	DT	0
fractions	fractions	NN	0
were	were	VBD	0
tested	tested	VBN	0
for	for	IN	0
APN	APN	NNP	B-NP
enzymatic	enzymatic	JJ	I-NP
activity	activity	NN	I-NP
by	by	IN	0
the	the	DT	0
LpNA	LpNA	JJ	B-NP
assay	assay	NN	I-NP
.	.	.	0
Briefly	Briefly	RB	0
,	,	,	0
390	390	CD	0
μl	μl	NN	B-NP
of	of	IN	0
sample	sample	NNS	0
are	are	VBP	0
mixed	mixed	VBN	0
with	with	IN	0
10	10	CD	0
μl	μl	NN	B-NP
of	of	IN	0
2	2	CD	0
mM	mM	JJ	B-NP
leucine-p-nitroanilide	leucine-p-nitroanilide	NN	I-NP
(	(	-LRB-	0
containing	containing	VBG	0
a	a	DT	0
leucine-phenylalanine	leucine-phenylalanine	JJ	B-NP
dipeptide	dipeptide	NN	I-NP
)	)	-RRB-	0
.	.	.	0
A	A	DT	0
yellow	yellow	JJ	0
chromophoric	chromophoric	JJ	B-NP
change	change	NN	I-NP
indicates	indicates	VBZ	0
aminopeptidase	aminopeptidase	JJ	B-NP
N	N	NNP	I-NP
activity	activity	NN	I-NP
,	,	,	0
defined	defined	VBN	0
as	as	IN	0
the	the	DT	0
ability	ability	NN	B-NP
to	to	TO	0
cleave	cleave	VB	0
a	a	DT	0
neutral	neutral	JJ	B-NP
amino	amino	JJ	I-NP
acid	acid	NN	I-NP
from	from	IN	0
the	the	DT	0
polypeptide	polypeptide	NN	B-NP
n-terminus	n-terminus	NN	I-NP
.	.	.	0
Cry1Aa	Cry1Aa	NNP	0
binding	binding	JJ	0
ability	ability	NN	B-NP
was	was	VBD	0
also	also	RB	0
checked	checked	VBN	0
by	by	IN	0
slot	slot	NN	0
blotting	blotting	VBG	B-NP
fraction	fraction	NN	I-NP
to	to	TO	0
PVDF	PVDF	NNP	B-NP
membrane	membrane	NN	I-NP
and	and	CC	0
probing	probing	VBG	0
with	with	IN	0
biotinylated	biotinylated	CD	0
Cry1Aa	Cry1Aa	CD	0
[	[	-LRB-	0
26	26	CD	0
]	]	-RRB-	0
.	.	.	0
Fractions	Fractions	NNS	0
with	with	IN	0
Cry1Aa-binding	Cry1Aa-binding	CD	0
ability	ability	NN	0
and	and	CC	0
APN	APN	NNP	B-NP
enzymatic	enzymatic	JJ	I-NP
activity	activity	NN	I-NP
were	were	VBD	0
concentrated	concentrated	VBN	0
to	to	TO	0
2	2	CD	0
ml	ml	CD	0
volumes	volumes	NNS	0
and	and	CC	0
loaded	loaded	VBN	0
on	on	IN	0
a	a	DT	0
Superdex	Superdex	NNP	B-NP
200	200	CD	0
size-exclusion	size-exclusion	JJ	B-NP
column	column	NN	I-NP
(	(	-LRB-	0
120	120	CD	0
ml	ml	JJ	B-NP
bed	bed	NN	I-NP
volume	volume	NN	I-NP
)	)	-RRB-	0
using	using	VBG	0
Hepes-buffered	Hepes-buffered	JJ	B-NP
saline	saline	NN	I-NP
(	(	-LRB-	0
hepes-buffered	hepes-buffered	NN	B-NP
saline	saline	JJ	I-NP
;	;	:	0
10	10	CD	0
mM	mM	JJ	0
Hepes	Hepes	NNP	0
,	,	,	0
150	150	CD	0
mM	mM	JJ	0
NaCl	NaCl	NN	0
,	,	,	0
3.4	3.4	CD	0
mM	mM	JJ	0
EDTA	EDTA	NNP	0
,	,	,	0
pH	pH	JJ	0
7.4	7.4	CD	0
)	)	-RRB-	0
as	as	IN	0
running	running	VBG	B-NP
buffer	buffer	NN	I-NP
.	.	.	0
Absorbance	Absorbance	NNP	B-NP
was	was	VBD	0
monitored	monitored	VBN	0
at	at	IN	0
280	280	CD	0
nm	nm	NN	B-NP
and	and	CC	0
260	260	CD	0
nm	nm	NN	B-NP
to	to	TO	0
judge	judge	VB	0
protein	protein	NN	B-NP
purity	purity	NN	I-NP
of	of	IN	0
collected	collected	JJ	0
peaks	peaks	NNS	0
relative	relative	JJ	0
to	to	TO	0
flow	flow	VB	0
through	through	RP	0
.	.	.	0
Fractions	Fractions	JJ	0
eluting	eluting	NN	B-NP
around	around	IN	0
115-120	115-120	NNP	0
kDa	kDa	NNP	B-NP
,	,	,	0
the	the	DT	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
mw	mw	NN	I-NP
,	,	,	0
were	were	VBD	0
collected	collected	VBN	0
and	and	CC	0
protease	protease	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
were	were	VBD	0
added	added	VBN	0
after	after	IN	0
a	a	DT	0
final	final	JJ	B-NP
concentration	concentration	NN	I-NP
.	.	.	0
anion-exchange	anion-exchange	NN	B-NP
fraction	fraction	NN	I-NP
with	with	IN	0
Cry1Aa-binding	Cry1Aa-binding	CD	0
ability	ability	NN	0
but	but	CC	0
without	without	IN	0
APN	APN	NNP	B-NP
enzymatic	enzymatic	JJ	I-NP
activity	activity	NN	I-NP
were	were	VBD	0
also	also	RB	0
size-purifed	size-purifed	JJ	B-NP
,	,	,	0
and	and	CC	0
fractions	fractions	JJ	0
eluting	eluting	NN	B-NP
around	around	IN	0
175-250	175-250	NNP	0
kDa	kDa	NNP	B-NP
,	,	,	0
the	the	DT	0
btr175	btr175	NN	B-NP
mw	mw	NN	I-NP
,	,	,	0
were	were	VBD	0
collected	collected	VBN	0
and	and	CC	0
concentrated	concentrated	JJ	0
.	.	.	0
Approximately	Approximately	RB	0
0.10	0.10	CD	0
mg	mg	NN	B-NP
(	(	-LRB-	0
in	in	IN	0
0.25	0.25	CD	0
ml	ml	CD	0
)	)	-RRB-	0
of	of	IN	0
cadherin-like	cadherin-like	JJ	B-NP
receptor	receptor	NN	I-NP
and	and	CC	0
0.30	0.30	CD	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
mg	mg	NN	I-NP
(	(	-LRB-	0
in	in	IN	0
1	1	CD	0
ml	ml	CD	0
)	)	-RRB-	0
were	were	VBD	0
obtained	obtained	VBN	0
.	.	.	0
Analysis	Analysis	NN	0
of	of	IN	0
receptor	receptor	NN	B-NP
purity	purity	NN	I-NP
candidate	candidate	NN	I-NP
receptor	receptor	NN	I-NP
fraction	fraction	NN	I-NP
were	were	VBD	0
analyzed	analyzed	VBN	0
by	by	IN	0
10	10	CD	0
%	%	NN	0
SDS-PAGE	SDS-PAGE	NN	B-NP
(	(	-LRB-	0
40	40	CD	0
μl	μl	CD	B-NP
/	/	CD	I-NP
lane	lane	CD	I-NP
)	)	-RRB-	0
and	and	CC	0
stained	stained	NN	0
with	with	IN	0
Coomassie	Coomassie	NNP	B-NP
brilliant	brilliant	JJ	0
blue	blue	NN	0
.	.	.	0
For	For	IN	0
slot	slot	JJ	B-NP
blot	blot	JJ	I-NP
assay	assay	NN	I-NP
,	,	,	0
5	5	CD	0
m.	m.	NN	B-NP
sexta	sexta	NN	I-NP
μg	μg	NN	I-NP
or	or	CC	0
b.	b.	NN	B-NP
mori	mori	VBD	I-NP
bbmv	bbmv	NN	I-NP
and	and	CC	0
40	40	CD	0
candidate	candidate	NN	B-NP
receptor	receptor	NN	I-NP
fraction	fraction	NN	I-NP
μl	μl	NN	I-NP
were	were	VBD	0
blotted	blotted	VBN	0
onto	onto	IN	0
PVDF	PVDF	NNP	B-NP
membrane	membrane	NN	I-NP
and	and	CC	0
assays	assays	NNS	0
was	was	VBD	0
carried	carried	VBN	0
out	out	RP	0
as	as	RB	0
reported	reported	VBD	0
previously	previously	RB	0
[	[	-LRB-	0
27	27	CD	0
]	]	-RRB-	0
,	,	,	0
except	except	IN	0
for	for	IN	0
using	using	VBG	0
1	1	CD	0
:	:	:	0
1000	1000	CD	0
anti-Bt-R	anti-Bt-R	JJ	B-NP
1	1	CD	0
polyclonal	polyclonal	CD	B-NP
antiserum	antiserum	NN	I-NP
.	.	.	0
For	For	IN	0
ligand	ligand	JJ	B-NP
blot	blot	JJ	I-NP
assay	assay	NN	I-NP
,	,	,	0
samples	samples	NNS	0
separated	separated	VBN	0
by	by	IN	0
SDS-PAGE	SDS-PAGE	NNP	B-NP
(	(	-LRB-	0
9	9	CD	0
%	%	NN	0
)	)	-RRB-	0
were	were	VBD	0
transferred	transferred	VBN	0
to	to	TO	0
PVDF	PVDF	NNP	B-NP
overnight	overnight	JJ	0
,	,	,	0
blocked	blocked	VBN	0
with	with	IN	0
5	5	CD	0
%	%	NN	0
dried	dried	VBD	0
milk	milk	NN	0
in	in	IN	0
ttb	ttb	NN	B-NP
(	(	-LRB-	0
50	50	CD	0
mM	mM	JJ	B-NP
Tris-HCl	Tris-HCl	NN	I-NP
,	,	,	0
150	150	CD	0
mM	mM	JJ	B-NP
NaCl	NaCl	NN	I-NP
,	,	,	0
0.05	0.05	CD	0
%	%	NN	0
Tween	Tween	NNP	B-NP
20	20	CD	0
,	,	,	0
pH	pH	JJ	0
7.5	7.5	CD	0
)	)	-RRB-	0
.	.	.	0
Samples	Samples	NNS	0
were	were	VBD	0
probed	probed	VBN	0
with	with	IN	0
50	50	CD	0
μg	μg	CD	0
biotin-Cry1Aa	biotin-Cry1Aa	CD	0
and	and	CC	0
streptavidin-conjugated	streptavidin-conjugated	JJ	B-NP
horseradish	horseradish	JJ	I-NP
peroxidase	peroxidase	NN	I-NP
for	for	IN	0
1	1	CD	0
hr	hr	CD	B-NP
each	each	DT	0
,	,	,	0
with	with	IN	0
45	45	CD	0
min	min	NNP	B-NP
ttb	ttb	NN	I-NP
wash	wash	NN	I-NP
,	,	,	0
and	and	CC	0
developed	developed	VBN	0
in	in	IN	0
DAB	DAB	NNP	B-NP
/	/	NNP	I-NP
Urea	Urea	NNP	I-NP
(	(	-LRB-	0
BioRad	BioRad	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
Surface	Surface	NN	0
plasmon	plasmon	NN	0
resonance	resonance	NN	0
with	with	IN	0
purified	purified	FW	0
midgut	midgut	FW	0
receptors	receptors	FW	0
B.	B.	NN	B-NP
mori	mori	NNP	I-NP
APN	APN	NNP	I-NP
and	and	CC	0
cadherin	cadherin	NN	B-NP
were	were	VBD	0
immobilized	immobilized	VBN	0
on	on	IN	0
a	a	DT	0
CM5	CM5	JJ	B-NP
sensor	sensor	JJ	I-NP
chip	chip	NN	I-NP
by	by	IN	0
the	the	DT	0
amine-coupling	amine-coupling	JJ	B-NP
method	method	NN	I-NP
(	(	-LRB-	0
Biacore	Biacore	NNP	B-NP
AB	AB	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
receptor	receptor	NN	B-NP
were	were	VBD	0
diluted	diluted	VBN	0
into	into	IN	0
ammonium	ammonium	JJ	B-NP
acetate	acetate	NN	I-NP
,	,	,	0
pH	pH	JJ	0
4.2	4.2	CD	0
prior	prior	JJ	0
to	to	TO	0
immobilization	immobilization	VB	B-NP
.	.	.	0
An	An	DT	0
hepe	hepe	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
(	(	-LRB-	0
pH	pH	NNP	B-NP
7.4	7.4	CD	0
)	)	-RRB-	0
buffer	buffer	NN	B-NP
flow	flow	NN	I-NP
rate	rate	NN	I-NP
of	of	IN	0
50	50	CD	0
μl	μl	CD	B-NP
/	/	CD	I-NP
min	min	NN	I-NP
was	was	VBD	0
used	used	VBN	0
for	for	IN	0
all	all	DT	0
injections	injections	NNS	0
.	.	.	0
randomized	randomized	NN	B-NP
toxin	toxin	NN	I-NP
concentration	concentration	NN	I-NP
varying	varying	VBG	0
from	from	IN	0
100	100	CD	0
nM	nM	JJ	0
to	to	TO	0
1000	1000	CD	0
nM	nM	NN	B-NP
were	were	VBD	0
injected	injected	VBN	0
(	(	-LRB-	0
110	110	CD	0
μl	μl	CD	B-NP
)	)	-RRB-	0
over	over	IN	0
the	the	DT	0
receptor	receptor	NN	B-NP
surface	surface	NN	I-NP
.	.	.	0
Surfaces	Surfaces	NNP	0
were	were	VBD	0
regenerated	regenerated	VBN	0
with	with	IN	0
6	6	CD	0
μl	μl	JJ	B-NP
pulse	pulse	NN	I-NP
of	of	IN	0
10	10	CD	0
mM	mM	JJ	B-NP
NaOH	NaOH	NN	I-NP
,	,	,	0
250	250	CD	0
μM	μM	JJ	B-NP
ethylene	ethylene	NN	I-NP
glycol	glycol	NN	I-NP
,	,	,	0
pH	pH	JJ	0
11.0	11.0	CD	0
at	at	IN	0
100	100	CD	0
μl	μl	CD	B-NP
/	/	CD	I-NP
min	min	NN	I-NP
.	.	.	0
signal	signal	JJ	B-NP
response	response	NN	I-NP
from	from	IN	0
a	a	DT	0
blank	blank	JJ	0
containing	containing	VBG	B-NP
ethanolamine	ethanolamine	NN	I-NP
flowcell	flowcell	NNS	I-NP
as	as	IN	0
a	a	DT	0
blocking	blocking	JJ	0
agent	agent	NN	B-NP
were	were	VBD	0
subtracted	subtracted	VBN	0
from	from	IN	0
all	all	DT	0
response	response	NN	B-NP
curve	curve	NN	I-NP
and	and	CC	0
data	data	NNS	0
were	were	VBD	0
fitted	fitted	VBN	0
using	using	VBG	0
BIAevaluation	BIAevaluation	JJ	0
3.0	3.0	CD	0
.	.	.	0
The	The	DT	0
curves	curves	NN	0
were	were	VBD	0
fit	fit	VBN	0
to	to	TO	0
a	a	DT	0
simple	simple	JJ	0
1	1	CD	0
:	:	:	0
1	1	CD	0
Langmuir	Langmuir	JJ	B-NP
binding	binding	JJ	I-NP
model	model	NN	I-NP
to	to	TO	0
obtain	obtain	VB	0
apparent	apparent	JJ	0
rate	rate	NN	B-NP
constant	constant	JJ	I-NP
(	(	-LRB-	0
A	A	DT	0
+	+	NNP	0
B	B	NNP	0
↔	↔	NNP	0
abbott	abbott	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
List	List	NN	0
of	of	IN	0
bacillus	bacillus	NN	B-NP
thuringiensi	thuringiensi	NN	I-NP
abbreviation	abbreviation	NN	I-NP
,	,	,	0
bacillus	bacillus	NN	B-NP
thuringiensi	thuringiensi	NN	I-NP
;	;	:	0
aminopeptidase	aminopeptidase	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
n	n	NN	I-NP
,	,	,	0
aminopeptidase	aminopeptidase	VBG	0
N	N	NNP	0
;	;	:	0
GPI	GPI	NNP	B-NP
,	,	,	0
glycosyl-phosphatidylinositol	glycosyl-phosphatidylinositol	JJ	B-NP
;	;	:	0
BBMV	BBMV	NNP	B-NP
,	,	,	0
brush	brush	NN	B-NP
border	border	NN	I-NP
membrane	membrane	NN	I-NP
vesicle	vesicle	NN	I-NP
;	;	:	0
LpNA	LpNA	NNP	B-NP
,	,	,	0
leucine-p-nitroanilide	leucine-p-nitroanilide	JJ	B-NP
;	;	:	0
phosphatidylinositol	phosphatidylinositol	NN	B-NP
specific	specific	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
phospholipase	phospholipase	NN	I-NP
c	c	NN	I-NP
,	,	,	0
phosphatidylinositol-specific	phosphatidylinositol-specific	JJ	B-NP
phospholipase	phospholipase	JJ	I-NP
C	C	NNP	0
;	;	:	0
hepe	hepe	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
,	,	,	0
Hepes-buffered	Hepes-buffered	JJ	B-NP
saline	saline	NN	I-NP
;	;	:	0
SPR	SPR	NNP	B-NP
,	,	,	0
surface	surface	NN	B-NP
plasmon	plasmon	NN	I-NP
resonance	resonance	NN	I-NP
